Hom_Normal_Prostate |
Normal_Prostate |
Normal Prostate tissue |
- |
hg38 |
90.35% |
81.88% |
87.87% |
84.12% |
30.03 |
99.90% |
Hom_Normal_Prostate_T2bN0M0_WT_N100_72yrs_Male |
Normal_Prostate_T2bN0M0_WT_N100_72yrs_Male |
Prostate Cancer (T2bN0M0) from 72-year-old male named N100 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
8,930.50% |
8,479.50% |
|
|
67.70 |
9,926.00% |
Hom_Normal_Prostate_T3bN0M0_WT_N103_68yrs_Male |
Normal_Prostate_T3bN0M0_WT_N103_68yrs_Male |
Prostate Cancer (T3bN0M0) from 68-year-old male named N103 with Wild-Type FOXA2 Mutation |
Male |
hg38 |
8,628.00% |
8,199.50% |
|
|
71.52 |
9,978.30% |
Hom_Normal_Prostate_T2bN0M0_InFrameDel_N109_66yrs_Male |
Normal_Prostate_T2bN0M0_InFrameDel_N109_66yrs_Male |
Prostate Cancer (T2bN0M0) from 66-year-old male named N109 with In_Frame_Del FOXA3 Mutation |
Male |
hg38 |
8,806.50% |
8,321.00% |
|
|
70.49 |
9,986.10% |
Hom_Normal_Prostate_T2bN0M0_WT_N10_65yrs_Male |
Normal_Prostate_T2bN0M0_WT_N10_65yrs_Male |
Prostate Cancer (T2bN0M0) from 65-year-old male named N10 with Wild-Type FOXA4 Mutation |
Male |
hg38 |
8,655.50% |
8,249.50% |
|
|
71.82 |
9,971.10% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N111_74yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N111_74yrs_Male |
Prostate Cancer (T2cN0M0) from 74-year-old male named N111 with In_Frame_Del FOXA5 Mutation |
Male |
hg38 |
8,359.00% |
7,941.00% |
|
|
77.60 |
9,981.15% |
Hom_Normal_Prostate_T3aN0M0_InFrameDel_N113_62yrs_Male |
Normal_Prostate_T3aN0M0_InFrameDel_N113_62yrs_Male |
Prostate Cancer (T3aN0M0) from 62-year-old male named N113 with In_Frame_Del FOXA6 Mutation |
Male |
hg38 |
8,933.50% |
8,482.00% |
|
|
68.73 |
9,983.60% |
Hom_Normal_Prostate_T2cN0M0_WT_N114_75yrs_Male |
Normal_Prostate_T2cN0M0_WT_N114_75yrs_Male |
Prostate Cancer (T2cN0M0) from 75-year-old male named N114 with Wild-Type FOXA7 Mutation |
Male |
hg38 |
8,617.00% |
8,216.00% |
|
|
68.73 |
9,928.10% |
Hom_Normal_Prostate_T1cN0M0_WT_N117_72yrs_Male |
Normal_Prostate_T1cN0M0_WT_N117_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named N117 with Wild-Type FOXA8 Mutation |
Male |
hg38 |
8,666.00% |
8,215.50% |
|
|
68.58 |
9,976.35% |
Hom_Normal_Prostate_T1cN0M0_WT_N120_68yrs_Male |
Normal_Prostate_T1cN0M0_WT_N120_68yrs_Male |
Prostate Cancer(T1cN0M0) from 68-year-old male named N120 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.75% |
83.38% |
|
|
66.82 |
99.51% |
Hom_Normal_Prostate_T1cN0M0_WT_N123_65yrs_Male |
Normal_Prostate_T1cN0M0_WT_N123_65yrs_Male |
Prostate Cancer(T1cN0M0) from 65-year-old male named N123 with Wild-Type FOXA1 Mutation |
male |
hg38 |
85.79% |
81.98% |
|
|
64.44 |
99.83% |
Hom_Normal_Prostate_T2cN0M0_WT_N124_66yrs_Male |
Normal_Prostate_T2cN0M0_WT_N124_66yrs_Male |
Prostate Cancer(T2cN0M0) from 66-year-old male named N124 with Wild-Type FOXA1 Mutation |
male |
hg38 |
80.33% |
76.66% |
|
|
67.03 |
99.81% |
Hom_Normal_Prostate_T3bN1M0_WT_N125_74yrs_Male |
Normal_Prostate_T3bN1M0_WT_N125_74yrs_Male |
Prostate Cancer(T3bN1M0) from 74-year-old male named N125 with Wild-Type FOXA1 Mutation |
male |
hg38 |
84.67% |
80.59% |
|
|
73.83 |
99.80% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N12_69yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N12_69yrs_Male |
Prostate Cancer (T2cN0M0) from 69-year-old male named N12 with In_Frame_Del FOXA9 Mutation |
Male |
hg38 |
8,733.50% |
8,334.50% |
|
|
72.02 |
9,980.90% |
Hom_Normal_Prostate_T2aN0M1b_WT_N131_61yrs_Male |
Normal_Prostate_T2aN0M1b_WT_N131_61yrs_Male |
Prostate Cancer(T2aN0M1b) from 61-year-old male named N131 with Wild-Type FOXA1 Mutation |
male |
hg38 |
84.51% |
80.93% |
|
|
66.12 |
99.77% |
Hom_Normal_Prostate_T2aN0M0_WT_N132_65yrs_Male |
Normal_Prostate_T2aN0M0_WT_N132_65yrs_Male |
Prostate Cancer(T2aN0M0) from 65-year-old male named N132 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.54% |
82.94% |
|
|
73.63 |
99.81% |
Hom_Normal_Prostate_T1cN0M0_FrameShiftDel_N133_69yrs_Male |
Normal_Prostate_T1cN0M0_FrameShiftDel_N133_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N133 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
84.57% |
79.98% |
|
|
69.52 |
99.67% |
Hom_Normal_Prostate_T2cN0M0_WT_N137_68yrs_Male |
Normal_Prostate_T2cN0M0_WT_N137_68yrs_Male |
Prostate Cancer(T2cN0M0) from 68-year-old male named N137 with Wild-Type FOXA1 Mutation |
male |
hg38 |
82.29% |
76.68% |
|
|
65.82 |
99.41% |
Hom_Normal_Prostate_T3bN0M0_MissenseMutation_N139_78yrs_Male |
Normal_Prostate_T3bN0M0_MissenseMutation_N139_78yrs_Male |
Prostate Cancer(T3bN0M0) from 78-year-old male named N139 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
85.96% |
81.62% |
|
|
63.06 |
99.33% |
Hom_Normal_Prostate_T2aN0M0_WT_N143_74yrs_Male |
Normal_Prostate_T2aN0M0_WT_N143_74yrs_Male |
Prostate Cancer(T2aN0M0) from 74-year-old male named N143 with Wild-Type FOXA1 Mutation |
male |
hg38 |
85.78% |
81.45% |
|
|
68.99 |
99.44% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N157_69yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N157_69yrs_Male |
Prostate Cancer(T2aN0M0) from 69-year-old male named N157 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.91% |
82.63% |
|
|
63.99 |
99.73% |
Hom_Normal_Prostate_T1cN0M0_WT_N160_72yrs_Male |
Normal_Prostate_T1cN0M0_WT_N160_72yrs_Male |
Prostate Cancer(T1cN0M0) from 72-year-old male named N160 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.99% |
84.84% |
|
|
77.02 |
99.49% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N162_60yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N162_60yrs_Male |
Prostate Cancer(T1cN0M0) from 60-year-old male named N162 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.96% |
83.97% |
|
|
66.21 |
99.52% |
Hom_Normal_Prostate_T3bN1M1c_WT_N166_67yrs_Male |
Normal_Prostate_T3bN1M1c_WT_N166_67yrs_Male |
Prostate Cancer(T3bN1M1c) from 67-year-old male named N166 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.36% |
82.50% |
|
|
61.35 |
99.83% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N167_74yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N167_74yrs_Male |
Prostate Cancer(T2cN0M0) from 74-year-old male named N167 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
80.15% |
76.67% |
|
|
69.41 |
99.84% |
Hom_Normal_Prostate_T2bN0M0_WT_N16_67yrs_Male |
Normal_Prostate_T2bN0M0_WT_N16_67yrs_Male |
Prostate Cancer(T2bN0M0) from 67-year-old male named N16 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.99% |
83.43% |
|
|
66.02 |
99.84% |
Hom_Normal_Prostate_T3aN0M0_WT_N172_67yrs_Male |
Normal_Prostate_T3aN0M0_WT_N172_67yrs_Male |
Prostate Cancer(T3aN0M0) from 67-year-old male named N172 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.98% |
82.98% |
|
|
65.96 |
99.22% |
Hom_Normal_Prostate_T3bN0M1b_InFrameDel_N174_68yrs_Male |
Normal_Prostate_T3bN0M1b_InFrameDel_N174_68yrs_Male |
Prostate Cancer(T3bN0M1b) from 68-year-old male named N174 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.26% |
82.91% |
|
|
78.59 |
99.17% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N176_69yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N176_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N176 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
90.19% |
85.66% |
|
|
60.60 |
99.75% |
Hom_Normal_Prostate_T2N0M0_WT_N178_65yrs_Male |
Normal_Prostate_T2N0M0_WT_N178_65yrs_Male |
Prostate Cancer(T2N0M0) from 65-year-old male named N178 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.83% |
83.38% |
|
|
65.17 |
99.34% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N17_61yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N17_61yrs_Male |
Prostate Cancer(T2cN0M0) from 61-year-old male named N17 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.44% |
84.00% |
|
|
86.39 |
99.77% |
Hom_Normal_Prostate_T1cN0M0_FrameShiftDel_N182_76yrs_Male |
Normal_Prostate_T1cN0M0_FrameShiftDel_N182_76yrs_Male |
Prostate Cancer(T1cN0M0) from 76-year-old male named N182 with Frame_Shift_Dell FOXA1 Mutation |
male |
hg38 |
88.20% |
84.17% |
|
|
71.64 |
99.54% |
Hom_Normal_Prostate_T2cN0M1b_WT_N185_64yrs_Male |
Normal_Prostate_T2cN0M1b_WT_N185_64yrs_Male |
Prostate Cancer(T2cN0M1b) from 64-year-old male named N185 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.41% |
84.97% |
|
|
60.21 |
99.72% |
Hom_Normal_Prostate_T1cN0M0_WT_N186_69yrs_Male |
Normal_Prostate_T1cN0M0_WT_N186_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N186 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.92% |
84.53% |
|
|
60.18 |
99.84% |
Hom_Normal_Prostate_T2bN0Mx_WT_N18_65yrs_Male |
Normal_Prostate_T2bN0Mx_WT_N18_65yrs_Male |
Prostate Cancer(T2bN0Mx) from 65-year-old male named N18 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.01% |
83.34% |
|
|
62.12 |
99.71% |
Hom_Normal_Prostate_T2bN0M0_WT_N196_59yrs_Male |
Normal_Prostate_T2bN0M0_WT_N196_59yrs_Male |
Prostate Cancer(T2bN0M0) from 59-year-old male named N196 with Wild-Type FOXA1 Mutation |
male |
hg38 |
90.58% |
86.18% |
|
|
61.01 |
99.15% |
Hom_Normal_Prostate_T1cN0M0_WT_N198_67yrs_Male |
Normal_Prostate_T1cN0M0_WT_N198_67yrs_Male |
Prostate Cancer(T1cN0M0) from 67-year-old male named N198 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.48% |
83.91% |
|
|
70.34 |
99.81% |
Hom_Normal_Prostate_T1cN0M0_WT_N19_75yrs_Male |
Normal_Prostate_T1cN0M0_WT_N19_75yrs_Male |
Prostate Cancer(T1cN0M0) from 75-year-old male named N19 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.88% |
83.36% |
|
|
68.66 |
99.83% |
Hom_Normal_Prostate_T3aN0M0_MissenseMutation_N1_70yrs_Male |
Normal_Prostate_T3aN0M0_MissenseMutation_N1_70yrs_Male |
Prostate Cancer (T3aN0M0) from 70-year-old male named N1 with Missense_Mutation FOXA10 Mutation |
Male |
hg38 |
8,794.00% |
8,349.50% |
|
|
64.74 |
9,956.60% |
Hom_Normal_Prostate_T3aN1M0_WT_N201_55yrs_Male |
Normal_Prostate_T3aN1M0_WT_N201_55yrs_Male |
Prostate Cancer(T3aN1M0) from 55-year-old male named N201 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.78% |
85.84% |
|
|
70.56 |
99.82% |
Hom_Normal_Prostate_T2aN0M0_MissenseMutation_N202_70yrs_Male |
Normal_Prostate_T2aN0M0_MissenseMutation_N202_70yrs_Male |
Prostate Cancer(MissenseMutation) from 70-year-old male named N202 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
86.69% |
82.40% |
|
|
72.17 |
99.82% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N208_71yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N208_71yrs_Male |
Prostate Cancer(InFrameDel) from 71-year-old male named N208 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.98% |
83.85% |
|
|
72.36 |
99.65% |
Hom_Normal_Prostate_T2aN0M0_WT_N209_62yrs_Male |
Normal_Prostate_T2aN0M0_WT_N209_62yrs_Male |
Prostate Cancer(T2aN0M0) from 62-year-old male named N209 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.30% |
82.74% |
|
|
72.96 |
99.77% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N210_74yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N210_74yrs_Male |
Prostate Cancer(T1cN0M0) from 74-year-old male named N210 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
89.20% |
85.58% |
|
|
77.52 |
99.83% |
Hom_Normal_Prostate_T2cN1M1b_InFrameDel_N211_71yrs_Male |
Normal_Prostate_T2cN1M1b_InFrameDel_N211_71yrs_Male |
Prostate Cancer(T2cN1M1b) from 71-year-old male named N211 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
79.46% |
75.73% |
|
|
76.26 |
99.70% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N213_69yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N213_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N213 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.86% |
83.64% |
|
|
73.10 |
99.74% |
Hom_Normal_Prostate_T2aN0M0_MissenseMutation_N215_64yrs_Male |
Normal_Prostate_T2aN0M0_MissenseMutation_N215_64yrs_Male |
Prostate Cancer(T2aN0M0) from 64-year-old male named N215 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
88.13% |
84.80% |
|
|
70.65 |
99.79% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N216_68yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N216_68yrs_Male |
Prostate Cancer(T1cN0M0) from 68-year-old male named N216 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
81.59% |
77.56% |
|
|
69.23 |
99.79% |
Hom_Normal_Prostate_T3aN1M0_WT_N217_79yrs_Male |
Normal_Prostate_T3aN1M0_WT_N217_79yrs_Male |
Prostate Cancer(T3aN1M0) from 79-year-old male named N217 with Wild-Type FOXA1 Mutation |
male |
hg38 |
79.64% |
76.42% |
|
|
86.61 |
99.79% |
Hom_Normal_Prostate_T1cN0M0_WT_N229_69yrs_Male |
Normal_Prostate_T1cN0M0_WT_N229_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N229 with Wild-Type FOXA1 Mutation |
male |
hg38 |
81.27% |
77.11% |
|
|
62.12 |
99.75% |
Hom_Normal_Prostate_T2aN0M0_WT_N22_76yrs_Male |
Normal_Prostate_T2aN0M0_WT_N22_76yrs_Male |
Prostate Cancer(T2aN0M0) from 76-year-old male named N22 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.68% |
85.38% |
|
|
64.85 |
99.43% |
Hom_Normal_Prostate_T2aN0M0_WT_N231_74yrs_Male |
Normal_Prostate_T2aN0M0_WT_N231_74yrs_Male |
Prostate Cancer(T2aN0M0) from 74-year-old male named N231 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.78% |
83.28% |
|
|
60.18 |
99.87% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N232_70yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N232_70yrs_Male |
Prostate Cancer(T2aN0M0) from 70-year-old male named N232 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
68.62% |
64.97% |
|
|
75.95 |
99.70% |
Hom_Normal_Prostate_T1aN0M1b_WT_N236_75yrs_Male |
Normal_Prostate_T1aN0M1b_WT_N236_75yrs_Male |
Prostate Cancer(T1aN0M1b) from 75-year-old male named N236 with Wild-Type FOXA1 Mutation |
male |
hg38 |
82.60% |
77.38% |
|
|
60.49 |
99.55% |
Hom_Normal_Prostate_T2cN0M0_FrameShiftDel_N250_72yrs_Male |
Normal_Prostate_T2cN0M0_FrameShiftDel_N250_72yrs_Male |
Prostate Cancer(T2cN0M0) from 72-year-old male named N250 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
80.32% |
76.63% |
|
|
75.64 |
99.79% |
Hom_Normal_Prostate_T2aN0M0_WT_N251_66yrs_Male |
Normal_Prostate_T2aN0M0_WT_N251_66yrs_Male |
Prostate Cancer(T2aN0M0) from 66-year-old male named N251 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.57% |
83.48% |
|
|
67.04 |
99.82% |
Hom_Normal_Prostate_T2aN0M0_WT_N258_68yrs_Male |
Normal_Prostate_T2aN0M0_WT_N258_68yrs_Male |
Prostate Cancer(T2aN0M0) from 68-year-old male named N258 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.69% |
82.46% |
|
|
63.66 |
99.81% |
Hom_Normal_Prostate_T1bN0M0_WT_N265_64yrs_Male |
Normal_Prostate_T1bN0M0_WT_N265_64yrs_Male |
Prostate Cancer(T1bN0M0) from 64-year-old male named N265 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.48% |
84.69% |
|
|
60.18 |
99.87% |
Hom_Normal_Prostate_T3aN0M0_WT_N268_61yrs_Male |
Normal_Prostate_T3aN0M0_WT_N268_61yrs_Male |
Prostate Cancer(T3aN0M0) from 61-year-old male named N268 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.80% |
86.76% |
|
|
65.91 |
99.72% |
Hom_Normal_Prostate_T2bN0M0_MissenseMutation_N26_67yrs_Male |
Normal_Prostate_T2bN0M0_MissenseMutation_N26_67yrs_Male |
Prostate Cancer(T2bN0M0) from 67-year-old male named N26 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.73% |
84.19% |
|
|
74.42 |
99.78% |
Hom_Normal_Prostate_T2bN0M0_MissenseMutation_N271_69yrs_Male |
Normal_Prostate_T2bN0M0_MissenseMutation_N271_69yrs_Male |
Prostate Cancer(T2bN0M0) from 69-year-old male named N271 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
88.50% |
84.11% |
|
|
62.10 |
99.85% |
Hom_Normal_Prostate_T1bN0M0_WT_N273_72yrs_Male |
Normal_Prostate_T1bN0M0_WT_N273_72yrs_Male |
Prostate Cancer(T1bN0M0) from 72-year-old male named N273 with Wild-Type FOXA1 Mutation |
male |
hg38 |
85.22% |
81.39% |
|
|
73.70 |
99.80% |
Hom_Normal_Prostate_T2cN0M0_WT_N279_78yrs_Male |
Normal_Prostate_T2cN0M0_WT_N279_78yrs_Male |
Prostate Cancer(T2cN0M0) from 78-year-old male named N279 with Wild-Type FOXA1 Mutation |
male |
hg38 |
74.36% |
70.86% |
|
|
61.07 |
99.84% |
Hom_Normal_Prostate_T2aN0M0_WT_N283_62yrs_Male |
Normal_Prostate_T2aN0M0_WT_N283_62yrs_Male |
Prostate Cancer(T2aN0M0) from 62-year-old male named N283 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.89% |
84.93% |
|
|
60.94 |
99.84% |
Hom_Normal_Prostate_T3bN0M0_WT_N286_71yrs_Male |
Normal_Prostate_T3bN0M0_WT_N286_71yrs_Male |
Prostate Cancer(T3bN0M0) from 71-year-old male named N286 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.53% |
84.34% |
|
|
70.45 |
99.60% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N289_64yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N289_64yrs_Male |
Prostate Cancer(T2aN0M0) from 64-year-old male named N289 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
85.63% |
81.99% |
|
|
64.24 |
99.81% |
Hom_Normal_Prostate_T3bN1M1a_FrameShiftDel_N28_68yrs_Male |
Normal_Prostate_T3bN1M1a_FrameShiftDel_N28_68yrs_Male |
Prostate Cancer(T3bN1M1a) from 68-year-old male named N28 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
89.72% |
85.50% |
|
|
72.95 |
99.63% |
Hom_Normal_Prostate_T2bN0M0_WT_N294_54yrs_Male |
Normal_Prostate_T2bN0M0_WT_N294_54yrs_Male |
Prostate Cancer(T2bN0M0) from 54-year-old male named N294 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.73% |
84.81% |
|
|
63.16 |
99.49% |
Hom_Normal_Prostate_T3aN0M0_InFrameDel_N300_71yrs_Male |
Normal_Prostate_T3aN0M0_InFrameDel_N300_71yrs_Male |
Prostate Cancer(T3aN0M0) from 71-year-old male named N300 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.20% |
83.94% |
|
|
65.99 |
99.87% |
Hom_Normal_Prostate_T1bN0M0_InFrameDel_N312_64yrs_Male |
Normal_Prostate_T1bN0M0_InFrameDel_N312_64yrs_Male |
Prostate Cancer(T1bN0M0) from 64-year-old male named N312 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
79.62% |
75.91% |
|
|
71.89 |
99.82% |
Hom_Normal_Prostate_T1cN0M0_WT_N313_62yrs_Male |
Normal_Prostate_T1cN0M0_WT_N313_62yrs_Male |
Prostate Cancer(T1cN0M0) from 62-year-old male named N313 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.13% |
84.28% |
|
|
62.55 |
99.72% |
Hom_Normal_Prostate_T1cN0M0_WT_N314_64yrs_Male |
Normal_Prostate_T1cN0M0_WT_N314_64yrs_Male |
Prostate Cancer(T1cN0M0) from 64-year-old male named N314 with Wild-Type FOXA1 Mutation |
male |
hg38 |
84.09% |
79.81% |
|
|
81.41 |
99.80% |
Hom_Normal_Prostate_T2cN0M0_FrameShiftDel_N315_78yrs_Male |
Normal_Prostate_T2cN0M0_FrameShiftDel_N315_78yrs_Male |
Prostate Cancer(T2cN0M0) from 78-year-old male named N315 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
86.77% |
82.88% |
|
|
65.63 |
99.67% |
Hom_Normal_Prostate_T1cN0M0_WT_N318_78yrs_Male |
Normal_Prostate_T1cN0M0_WT_N318_78yrs_Male |
Prostate Cancer(T1cN0M0) from 78-year-old male named N318 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.16% |
83.77% |
|
|
63.22 |
99.83% |
Hom_Normal_Prostate_T2aN0M0_WT_N319_69yrs_Male |
Normal_Prostate_T2aN0M0_WT_N319_69yrs_Male |
Prostate Cancer(T2aN0M0) from 69-year-old male named N319 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.34% |
83.79% |
|
|
66.48 |
99.88% |
Hom_Normal_Prostate_T3aNXM0_InFrameDel_N31_66yrs_Male |
Normal_Prostate_T3aNXM0_InFrameDel_N31_66yrs_Male |
Prostate Cancer(T3aNXM0) from 66-year-old male named N31 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.39% |
84.00% |
|
|
77.89 |
99.82% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N321_73yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N321_73yrs_Male |
Prostate Cancer(T1cN0M0) from 73-year-old male named N321 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
89.52% |
84.86% |
|
|
67.37 |
99.60% |
Hom_Normal_Prostate_T2cN0M0_MissenseMutation_N325_76yrs_Male |
Normal_Prostate_T2cN0M0_MissenseMutation_N325_76yrs_Male |
Prostate Cancer(T2cN0M0) from 76-year-old male named N325 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.90% |
83.58% |
|
|
72.96 |
99.83% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N326_63yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N326_63yrs_Male |
Prostate Cancer(T2aN0M0) from 63-year-old male named N326 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.41% |
82.30% |
|
|
80.92 |
99.78% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N329_71yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N329_71yrs_Male |
Prostate Cancer(T1cN0M0) from 71-year-old male named N329 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.28% |
84.41% |
|
|
70.00 |
99.88% |
Hom_Normal_Prostate_T1cN0M0_WT_N32_88yrs_Male |
Normal_Prostate_T1cN0M0_WT_N32_88yrs_Male |
Prostate Cancer(T1cN0M0) from 88-year-old male named N32 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.56% |
83.23% |
|
|
68.42 |
99.83% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N330_70yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N330_70yrs_Male |
Prostate Cancer(T2cN0M0) from 70-year-old male named N330 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
83.43% |
79.09% |
|
|
65.13 |
99.80% |
Hom_Normal_Prostate_T2aN0M0_WT_N331_74yrs_Male |
Normal_Prostate_T2aN0M0_WT_N331_74yrs_Male |
Prostate Cancer(T2aN0M0) from 74-year-old male named N331 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.66% |
84.55% |
|
|
72.33 |
99.77% |
Hom_Normal_Prostate_T0N0M0_WT_N332_68yrs_Male |
Normal_Prostate_T0N0M0_WT_N332_68yrs_Male |
Prostate Cancer(T0N0M0) from 68-year-old male named N332 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.33% |
84.38% |
|
|
69.05 |
99.71% |
Hom_Normal_Prostate_T2cN0M0_WT_N334_79yrs_Male |
Normal_Prostate_T2cN0M0_WT_N334_79yrs_Male |
Prostate Cancer(T2cN0M0) from 79-year-old male named N334 with Wild-Type FOXA1 Mutation |
male |
hg38 |
81.28% |
77.14% |
|
|
72.23 |
99.83% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N335_64yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N335_64yrs_Male |
Prostate Cancer(T1cN0M0) from 64-year-old male named N335 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
85.75% |
81.77% |
|
|
67.98 |
99.84% |
Hom_Normal_Prostate_T2bN0M0_FrameShiftDel_N339_66yrs_Male |
Normal_Prostate_T2bN0M0_FrameShiftDel_N339_66yrs_Male |
Prostate Cancer(T2bN0M0) from 66-year-old male named N339 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
88.33% |
84.23% |
|
|
70.08 |
99.81% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N340_78yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N340_78yrs_Male |
Prostate Cancer(T2cN0M0) from 78-year-old male named N340 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.90% |
82.82% |
|
|
72.68 |
99.79% |
Hom_Normal_Prostate_T3aN0M0_WT_N342_71yrs_Male |
Normal_Prostate_T3aN0M0_WT_N342_71yrs_Male |
Prostate Cancer(T3aN0M0) from 71-year-old male named N342 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.02% |
85.09% |
|
|
69.01 |
99.67% |
Hom_Normal_Prostate_T2cN0M0_MissenseMutation_N349_73yrs_Male |
Normal_Prostate_T2cN0M0_MissenseMutation_N349_73yrs_Male |
Prostate Cancer(T2cN0M0) from 73-year-old male named N349 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
84.71% |
80.44% |
|
|
86.38 |
99.84% |
Hom_Normal_Prostate_T2aN0M0_WT_N34_64yrs_Male |
Normal_Prostate_T2aN0M0_WT_N34_64yrs_Male |
Prostate Cancer(T2aN0M0) from 64-year-old male named N34 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.44% |
84.66% |
|
|
86.31 |
99.78% |
Hom_Normal_Prostate_T1bN0M0_InFrameDel_N358_68yrs_Male |
Normal_Prostate_T1bN0M0_InFrameDel_N358_68yrs_Male |
Prostate Cancer(T1bN0M0) from 68-year-old male named N358 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
90.63% |
85.77% |
|
|
67.64 |
99.80% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N361_60yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N361_60yrs_Male |
Prostate Cancer(T1cN0M0) from 60-year-old male named N361 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
91.01% |
86.65% |
|
|
61.10 |
99.83% |
Hom_Normal_Prostate_T1aN0M0_WT_N367_62yrs_Male |
Normal_Prostate_T1aN0M0_WT_N367_62yrs_Male |
Prostate Cancer(T1aN0M0) from 62-year-old male named N367 with Wild-Type FOXA1 Mutation |
male |
hg38 |
91.25% |
86.92% |
|
|
61.78 |
99.84% |
Hom_Normal_Prostate_T2aN0M1b_InFrameDel_N36_77yrs_Male |
Normal_Prostate_T2aN0M1b_InFrameDel_N36_77yrs_Male |
Prostate Cancer(T2aN0M1b) from 77-year-old male named N36 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
65.74% |
62.96% |
|
|
65.61 |
99.55% |
Hom_Normal_Prostate_T2cN0M0_WT_N373_61yrs_Male |
Normal_Prostate_T2cN0M0_WT_N373_61yrs_Male |
Prostate Cancer(T2cN0M0) from 61-year-old male named N373 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.04% |
83.83% |
|
|
138.76 |
99.83% |
Hom_Normal_Prostate_T2cN0M0_WT_N375_66yrs_Male |
Normal_Prostate_T2cN0M0_WT_N375_66yrs_Male |
Prostate Cancer(T2cN0M0) from 66-year-old male named N375 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.92% |
83.44% |
|
|
136.14 |
99.84% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N378_73yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N378_73yrs_Male |
Prostate Cancer(T1cN0M0) from 73-year-old male named N378 with In_Frame_DelFOXA1 Mutation |
male |
hg38 |
86.97% |
83.09% |
|
|
76.36 |
99.81% |
Hom_Normal_Prostate_T2bN0M0_WT_N379_80yrs_Male |
Normal_Prostate_T2bN0M0_WT_N379_80yrs_Male |
Prostate Cancer(T2bN0M0) from 80-year-old male named N379 with Wild-Type FOXA1 Mutation |
male |
hg38 |
90.34% |
85.73% |
|
|
69.51 |
99.81% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N380_69yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N380_69yrs_Male |
Prostate Cancer(T1cN0M0) from 69-year-old male named N380 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
89.00% |
85.00% |
|
|
69.23 |
99.78% |
Hom_Normal_Prostate_T2bN0M0_WT_N384_64yrs_Male |
Normal_Prostate_T2bN0M0_WT_N384_64yrs_Male |
Prostate Cancer(T2bN0M0) from 64-year-old male named N384 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.05% |
83.83% |
|
|
70.90 |
99.80% |
Hom_Normal_Prostate_T1cN0M0_WT_N385_58yrs_Male |
Normal_Prostate_T1cN0M0_WT_N385_58yrs_Male |
Prostate Cancer(T1cN0M0) from 58-year-old male named N385 with Wild-Type FOXA1 Mutation |
male |
hg38 |
83.62% |
79.55% |
|
|
72.41 |
99.82% |
Hom_Normal_Prostate_T3aN0M0_WT_N389_74yrs_Male |
Normal_Prostate_T3aN0M0_WT_N389_74yrs_Male |
Prostate Cancer(T3aN0M0) from 74-year-old male named N389 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.46% |
82.98% |
|
|
73.71 |
99.81% |
Hom_Normal_Prostate_T2aN0M0_WT_N391_64yrs_Male |
Normal_Prostate_T2aN0M0_WT_N391_64yrs_Male |
Prostate Cancer(T2aN0M0) from 64-year-old male named N391 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.35% |
82.36% |
|
|
67.01 |
99.83% |
Hom_Normal_Prostate_T1bN0M0_WT_N393_67yrs_Male |
Normal_Prostate_T1bN0M0_WT_N393_67yrs_Male |
Prostate Cancer(T1bN0M0) from 67-year-old male named N393 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.95% |
84.44% |
|
|
69.19 |
99.82% |
Hom_Normal_Prostate_T1cN0M0_WT_N396_58yrs_Male |
Normal_Prostate_T1cN0M0_WT_N396_58yrs_Male |
Prostate Cancer(T1cN0M0) from 58-year-old male named N396 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.82% |
84.38% |
|
|
74.91 |
99.86% |
Hom_Normal_Prostate_T1cN0M0_WT_N405_67yrs_Male |
Normal_Prostate_T1cN0M0_WT_N405_67yrs_Male |
Prostate Cancer(T1cN0M0) from 67-year-old male named N405 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.49% |
84.89% |
|
|
76.14 |
99.84% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N408_78yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N408_78yrs_Male |
Prostate Cancer(T2aN0M0) from 78-year-old male named N408 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.38% |
84.75% |
|
|
62.52 |
99.78% |
Hom_Normal_Prostate_T2cN0Mx_InFrameDel_N410_80yrs_Male |
Normal_Prostate_T2cN0Mx_InFrameDel_N410_80yrs_Male |
Prostate Cancer(T2cN0Mx) from 80-year-old male named N410 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.53% |
85.93% |
|
|
81.14 |
99.43% |
Hom_Normal_Prostate_T2aN0Mx_WT_N411_63yrs_Male |
Normal_Prostate_T2aN0Mx_WT_N411_63yrs_Male |
Prostate Cancer(T2aN0Mx) from 63-year-old male named N411 with Wild-Type FOXA1 Mutation |
male |
hg38 |
91.61% |
87.76% |
|
|
60.20 |
99.87% |
Hom_Normal_Prostate_T2bN1M0_WT_N42_68yrs_Male |
Normal_Prostate_T2bN1M0_WT_N42_68yrs_Male |
Prostate Cancer(T2bN1M0) from 68-year-old male named N42 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.82% |
85.70% |
|
|
68.28 |
99.55% |
Hom_Normal_Prostate_T2cN0M0_WT_N43_72yrs_Male |
Normal_Prostate_T2cN0M0_WT_N43_72yrs_Male |
Prostate Cancer(T2cN0M0) from 72-year-old male named N43 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.13% |
84.62% |
|
|
78.16 |
99.75% |
Hom_Normal_Prostate_T1cN0M0_WT_N431_61yrs_Male |
Normal_Prostate_T1cN0M0_WT_N431_61yrs_Male |
Prostate Cancer(T1cN0M0) from 61-year-old male named N431 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.98% |
85.12% |
|
|
66.17 |
99.87% |
Hom_Normal_Prostate_T2aN0M0_WT_N434_69yrs_Male |
Normal_Prostate_T2aN0M0_WT_N434_69yrs_Male |
Prostate Cancer(T2aN0M0) from 69-year-old male named N434 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.95% |
85.45% |
|
|
64.55 |
99.83% |
Hom_Normal_Prostate_T2bN0M0_WT_N465_80yrs_Male |
Normal_Prostate_T2bN0M0_WT_N465_80yrs_Male |
Prostate Cancer(T2bN0M0) from 80-year-old male named N465 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.89% |
84.64% |
|
|
84.00 |
99.52% |
Hom_Normal_Prostate_T2cN0M0_WT_N467_56yrs_Male |
Normal_Prostate_T2cN0M0_WT_N467_56yrs_Male |
Prostate Cancer(T2cN0M0) from 56-year-old male named N467 with Wild-Type FOXA1 Mutation |
male |
hg38 |
83.80% |
80.27% |
|
|
70.94 |
99.81% |
Hom_Normal_Prostate_T2aN0M0_FrameShiftIns_N471_70yrs_Male |
Normal_Prostate_T2aN0M0_FrameShiftIns_N471_70yrs_Male |
Prostate Cancer(T2aN0M0) from 70-year-old male named N471 with Frame_Shift_Ins FOXA1 Mutation |
male |
hg38 |
87.26% |
83.22% |
|
|
73.86 |
99.81% |
Hom_Normal_Prostate_T2aN0M0_WT_N473_59yrs_Male |
Normal_Prostate_T2aN0M0_WT_N473_59yrs_Male |
Prostate Cancer(T2aN0M0) from 59-year-old male named N473 with Wild-Type FOXA1 Mutation |
male |
hg38 |
88.83% |
85.59% |
|
|
68.35 |
99.81% |
Hom_Normal_Prostate_T1cN1M0_WT_N476_55yrs_Male |
Normal_Prostate_T1cN1M0_WT_N476_55yrs_Male |
Prostate Cancer(T1cN1M0) from 55-year-old male named N476 with Wild-Type FOXA1 Mutation |
male |
hg38 |
89.76% |
85.81% |
|
|
65.93 |
99.61% |
Hom_Normal_Prostate_T2bN1M0_WT_N477_73yrs_Male |
Normal_Prostate_T2bN1M0_WT_N477_73yrs_Male |
Prostate Cancer(T2bN1M0) from 73-year-old male named N477 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.72% |
84.13% |
|
|
62.74 |
99.80% |
Hom_Normal_Prostate_T2cN0M0_WT_N47_70yrs_Male |
Normal_Prostate_T2cN0M0_WT_N47_70yrs_Male |
Prostate Cancer(T2cN0M0) from 70-year-old male named N47 with Wild-Type FOXA1 Mutation |
male |
hg38 |
86.13% |
81.19% |
|
|
60.36 |
99.42% |
Hom_Normal_Prostate_T2bN0M0_FrameShiftDel_N480_76yrs_Male |
Normal_Prostate_T2bN0M0_FrameShiftDel_N480_76yrs_Male |
Prostate Cancer (T2bN0M0) from 76-year-old male named N480 with Frame_Shift_Del FOXA11 Mutation |
Male |
hg38 |
8,782.00% |
8,463.00% |
|
|
66.58 |
9,983.00% |
Hom_Normal_Prostate_T1cN0M0_FrameShiftDel_N482_77yrs_Male |
Normal_Prostate_T1cN0M0_FrameShiftDel_N482_77yrs_Male |
Prostate Cancer (T1cN0M0) from 77-year-old male named N482 with Frame_Shift_Del FOXA12 Mutation |
Male |
hg38 |
8,868.00% |
8,464.00% |
|
|
69.57 |
9,984.65% |
Hom_Normal_Prostate_N0M1b_WT_N487_82yrs_Male |
Normal_Prostate_N0M1b_WT_N487_82yrs_Male |
Prostate Cancer (N0M1b) from 82-year-old male named N487 with Wild-Type FOXA13 Mutation |
Male |
hg38 |
8,730.00% |
8,341.00% |
|
|
68.21 |
9,981.40% |
Hom_Normal_Prostate_T2cN1M1b_WT_N491_71yrs_Male |
Normal_Prostate_T2cN1M1b_WT_N491_71yrs_Male |
Prostate Cancer (T2cN1M1b) from 71-year-old male named N491 with Wild-Type FOXA14 Mutation |
Male |
hg38 |
9,025.50% |
8,623.00% |
|
|
70.51 |
9,971.55% |
Hom_Normal_Prostate_T3bN0M0_WT_N496_66yrs_Male |
Normal_Prostate_T3bN0M0_WT_N496_66yrs_Male |
Prostate Cancer (T3bN0M0) from 66-year-old male named N496 with Wild-Type FOXA15 Mutation |
Male |
hg38 |
9,075.50% |
8,723.50% |
|
|
69.44 |
9,973.30% |
Hom_Normal_Prostate_T1cN0M0_WT_N498_65yrs_Male |
Normal_Prostate_T1cN0M0_WT_N498_65yrs_Male |
Prostate Cancer (T1cN0M0) from 65-year-old male named N498 with Wild-Type FOXA16 Mutation |
Male |
hg38 |
7,679.50% |
7,363.00% |
|
|
63.51 |
9,971.80% |
Hom_Normal_Prostate_T3bN0M1b_WT_N502_62yrs_Male |
Normal_Prostate_T3bN0M1b_WT_N502_62yrs_Male |
Prostate Cancer (T3bN0M1b) from 62-year-old male named N502 with Wild-Type FOXA17 Mutation |
Male |
hg38 |
7,626.00% |
7,266.00% |
|
|
68.43 |
9,969.10% |
Hom_Normal_Prostate_T2N0M0_MissenseMutation_N508_71yrs_Male |
Normal_Prostate_T2N0M0_MissenseMutation_N508_71yrs_Male |
Prostate Cancer (T2N0M0) from 71-year-old male named N508 with Missense_Mutation FOXA18 Mutation |
Male |
hg38 |
8,869.50% |
8,407.00% |
|
|
67.04 |
9,987.55% |
Hom_Normal_Prostate_T2N0M0_WT_N509_70yrs_Male |
Normal_Prostate_T2N0M0_WT_N509_70yrs_Male |
Prostate Cancer (T2N0M0) from 70-year-old male named N509 with Wild-Type FOXA19 Mutation |
Male |
hg38 |
8,386.50% |
7,962.00% |
|
|
74.84 |
9,987.85% |
Hom_Normal_Prostate_T1cN0M0_WT_N50_78yrs_Male |
Normal_Prostate_T1cN0M0_WT_N50_78yrs_Male |
Prostate Cancer (T1cN0M0) from 78-year-old male named N50 with Wild-Type FOXA20 Mutation |
Male |
hg38 |
8,807.50% |
8,381.50% |
|
|
64.76 |
9,937.75% |
Hom_Normal_Prostate_T1cN0M0_WT_N512_68yrs_Male |
Normal_Prostate_T1cN0M0_WT_N512_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named N512 with Wild-Type FOXA21 Mutation |
Male |
hg38 |
8,583.50% |
8,151.00% |
|
|
69.98 |
9,951.25% |
Hom_Normal_Prostate_T1cN0M1b_WT_N513_78yrs_Male |
Normal_Prostate_T1cN0M1b_WT_N513_78yrs_Male |
Prostate Cancer (T1cN0M1b) from 78-year-old male named N513 with Wild-Type FOXA22 Mutation |
Male |
hg38 |
8,053.50% |
7,634.50% |
|
|
75.14 |
9,985.25% |
Hom_Normal_Prostate_T1cN0M0_WT_N515_70yrs_Male |
Normal_Prostate_T1cN0M0_WT_N515_70yrs_Male |
Prostate Cancer (T1cN0M0) from 70-year-old male named N515 with Wild-Type FOXA23 Mutation |
Male |
hg38 |
8,849.00% |
8,446.50% |
|
|
64.04 |
9,980.15% |
Hom_Normal_Prostate_T2aN0Mx_NonsenseMutation_N521_61yrs_Male |
Normal_Prostate_T2aN0Mx_NonsenseMutation_N521_61yrs_Male |
Prostate Cancer (T2aN0Mx) from 61-year-old male named N521 with Nonsense_Mutation FOXA24 Mutation |
Male |
hg38 |
8,076.00% |
7,651.50% |
|
|
69.51 |
9,986.05% |
Hom_Normal_Prostate_T1cN0M0_WT_N52_64yrs_Male |
Normal_Prostate_T1cN0M0_WT_N52_64yrs_Male |
Prostate Cancer (T1cN0M0) from 64-year-old male named N52 with Wild-Type FOXA25 Mutation |
Male |
hg38 |
9,073.50% |
8,684.00% |
|
|
72.22 |
9,978.00% |
Hom_Normal_Prostate_T2cN0M0_MissenseMutation_N53_65yrs_Male |
Normal_Prostate_T2cN0M0_MissenseMutation_N53_65yrs_Male |
Prostate Cancer (T2cN0M0) from 65-year-old male named N53 with Missense_Mutation FOXA26 Mutation |
Male |
hg38 |
8,760.00% |
8,335.00% |
|
|
68.04 |
9,907.90% |
Hom_Normal_Prostate_T2N0M0_WT_N546_71yrs_Male |
Normal_Prostate_T2N0M0_WT_N546_71yrs_Male |
Prostate Cancer (T2N0M0) from 71-year-old male named N546 with Wild-Type FOXA27 Mutation |
Male |
hg38 |
8,856.50% |
8,439.00% |
|
|
65.89 |
9,985.55% |
Hom_Normal_Prostate_T2bN0M0_WT_N54_67yrs_Male |
Normal_Prostate_T2bN0M0_WT_N54_67yrs_Male |
Prostate Cancer (T2bN0M0) from 67-year-old male named N54 with Wild-Type FOXA28 Mutation |
Male |
hg38 |
8,874.50% |
8,439.00% |
|
|
74.17 |
9,941.75% |
Hom_Normal_Prostate_T2aN0M0_WT_N551_78yrs_Male |
Normal_Prostate_T2aN0M0_WT_N551_78yrs_Male |
Prostate Cancer (T2aN0M0) from 78-year-old male named N551 with Wild-Type FOXA29 Mutation |
Male |
hg38 |
9,016.00% |
8,608.00% |
|
|
77.32 |
9,981.05% |
Hom_Normal_Prostate_T2aN0M0_WT_N556_73yrs_Male |
Normal_Prostate_T2aN0M0_WT_N556_73yrs_Male |
Prostate Cancer (T2aN0M0) from 73-year-old male named N556 with Wild-Type FOXA30 Mutation |
Male |
hg38 |
8,882.00% |
8,474.50% |
|
|
64.28 |
9,983.85% |
Hom_Normal_Prostate_T2aN0Mx_InFrameDel_N558_74yrs_Male |
Normal_Prostate_T2aN0Mx_InFrameDel_N558_74yrs_Male |
Prostate Cancer (T2aN0Mx) from 74-year-old male named N558 with In_Frame_Del FOXA31 Mutation |
Male |
hg38 |
8,738.00% |
8,325.50% |
|
|
64.81 |
9,983.20% |
Hom_Normal_Prostate_T2aN0Mx_MissenseMutation_N563_67yrs_Male |
Normal_Prostate_T2aN0Mx_MissenseMutation_N563_67yrs_Male |
Prostate Cancer (T2aN0Mx) from 67-year-old male named N563 with Missense_Mutation FOXA32 Mutation |
Male |
hg38 |
8,708.50% |
8,241.50% |
|
|
74.02 |
9,984.35% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N565_66yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N565_66yrs_Male |
Prostate Cancer (T1cN0M0) from 66-year-old male named N565 with Missense_Mutation FOXA33 Mutation |
Male |
hg38 |
8,554.50% |
8,060.00% |
|
|
79.15 |
9,977.15% |
Hom_Normal_Prostate_T2cN0M0_MissenseMutation_N56_75yrs_Male |
Normal_Prostate_T2cN0M0_MissenseMutation_N56_75yrs_Male |
Prostate Cancer (T2cN0M0) from 75-year-old male named N56 with Missense_Mutation FOXA34 Mutation |
Male |
hg38 |
8,698.50% |
8,330.50% |
|
|
77.63 |
9,973.65% |
Hom_Normal_Prostate_T2cN0M0_WT_N574_79yrs_Male |
Normal_Prostate_T2cN0M0_WT_N574_79yrs_Male |
Prostate Cancer (T2cN0M0) from 79-year-old male named N574 with Wild-Type FOXA35 Mutation |
Male |
hg38 |
8,656.50% |
8,216.50% |
|
|
74.69 |
9,978.90% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N576_68yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N576_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named N576 with Missense_Mutation FOXA36 Mutation |
Male |
hg38 |
8,777.50% |
8,359.00% |
|
|
68.91 |
9,979.45% |
Hom_Normal_Prostate_T1cN0M0_WT_N577_74yrs_Male |
Normal_Prostate_T1cN0M0_WT_N577_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named N577 with Wild-Type FOXA37 Mutation |
Male |
hg38 |
8,831.00% |
8,400.50% |
|
|
76.94 |
9,980.60% |
Hom_Normal_Prostate_T2cN0M0_WT_N578_79yrs_Male |
Normal_Prostate_T2cN0M0_WT_N578_79yrs_Male |
Prostate Cancer (T2cN0M0) from 79-year-old male named N578 with Wild-Type FOXA38 Mutation |
Male |
hg38 |
8,265.50% |
7,881.00% |
|
|
66.91 |
9,980.45% |
Hom_Normal_Prostate_T2cN0M0_MissenseMutation_N57_72yrs_Male |
Normal_Prostate_T2cN0M0_MissenseMutation_N57_72yrs_Male |
Prostate Cancer (T2cN0M0) from 72-year-old male named N57 with Missense_Mutation FOXA39 Mutation |
Male |
hg38 |
8,729.50% |
8,348.00% |
|
|
76.35 |
9,965.00% |
Hom_Normal_Prostate_T2cN1M0_WT_N585_78yrs_Male |
Normal_Prostate_T2cN1M0_WT_N585_78yrs_Male |
Prostate Cancer(T2cN1M0) from 78-year-old male named N585 with Wild-Type FOXA1 Mutation |
male |
hg38 |
87.20% |
83.13% |
|
|
63.15 |
99.80% |
Hom_Normal_Prostate_T2aN0M0_MissenseMutation_N587_76yrs_Male |
Normal_Prostate_T2aN0M0_MissenseMutation_N587_76yrs_Male |
Prostate Cancer(T2aN0M0) from 76-year-old male named N587 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
86.80% |
82.36% |
|
|
66.19 |
99.86% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N58_69yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N58_69yrs_Male |
Prostate Cancer (T2aN0M0) from 69-year-old male named N58 with In_Frame_Del FOXA40 Mutation |
Male |
hg38 |
8,874.00% |
8,484.00% |
|
|
74.42 |
9,922.25% |
Hom_Normal_Prostate_T1cN0M0_MissenseMutation_N592_72yrs_Male |
Normal_Prostate_T1cN0M0_MissenseMutation_N592_72yrs_Male |
Prostate Cancer(T1cN0M0) from 72-year-old male named N592 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
86.70% |
82.64% |
|
|
78.72 |
99.85% |
Hom_Normal_Prostate_T2aN0M0_WT_N595_68yrs_Male |
Normal_Prostate_T2aN0M0_WT_N595_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named N595 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.70% |
82.03% |
|
|
64.95 |
99.87% |
Hom_Normal_Prostate_T2aN0M0_WT_N597_66yrs_Male |
Normal_Prostate_T2aN0M0_WT_N597_66yrs_Male |
Prostate Cancer (T2aN0M0) from 66-year-old male named N597 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.39% |
85.19% |
|
|
67.26 |
99.86% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N600_72yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N600_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named N600 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.19% |
82.95% |
|
|
69.48 |
99.85% |
Hom_Normal_Prostate_T3bN0M0_WT_N605_70yrs_Male |
Normal_Prostate_T3bN0M0_WT_N605_70yrs_Male |
Prostate Cancer (T3bN0M0) from 70-year-old male named N605 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.73% |
82.45% |
|
|
75.90 |
99.86% |
Hom_Normal_Prostate_T2aN0M1b_MissenseMutation_N607_68yrs_Male |
Normal_Prostate_T2aN0M1b_MissenseMutation_N607_68yrs_Male |
Prostate Cancer (T2aN0M1b) from 68-year-old male named N607 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.34% |
83.58% |
|
|
68.75 |
99.85% |
Hom_Normal_Prostate_T2cN0M1b_MissenseMutation_N608_50yrs_Male |
Normal_Prostate_T2cN0M1b_MissenseMutation_N608_50yrs_Male |
Prostate Cancer (T2cN0M1b) from 50-year-old male named N608 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.96% |
83.96% |
|
|
64.11 |
99.86% |
Hom_Normal_Prostate_T1cN0M1b_InFrameDel_N609_62yrs_Male |
Normal_Prostate_T1cN0M1b_InFrameDel_N609_62yrs_Male |
Prostate Cancer (T1cN0M1b) from 62-year-old male named N609 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.14% |
83.00% |
|
|
78.38 |
99.86% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N60_77yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N60_77yrs_Male |
Prostate Cancer (T2cN0M0) from 77-year-old male named N60 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.22% |
84.87% |
|
|
68.42 |
99.57% |
Hom_Normal_Prostate_T3aN0M0_WT_N61_70yrs_Male |
Normal_Prostate_T3aN0M0_WT_N61_70yrs_Male |
Prostate Cancer (T3aN0M0) from 70-year-old male named N61 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.05% |
84.78% |
|
|
62.75 |
99.51% |
Hom_Normal_Prostate_T2aN0M1b_WT_N611_76yrs_Male |
Normal_Prostate_T2aN0M1b_WT_N611_76yrs_Male |
Prostate Cancer (T2aN0M1b) from 76-year-old male named N611 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.04% |
83.43% |
|
|
69.51 |
99.88% |
Hom_Normal_Prostate_NAN0M0_InFrameDel_N612_77yrs_Male |
Normal_Prostate_NAN0M0_InFrameDel_N612_77yrs_Male |
Prostate Cancer (NAN0M0) from 77-year-old male named N612 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.61% |
84.25% |
|
|
69.03 |
99.83% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N613_68yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N613_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named N613 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
85.82% |
82.53% |
|
|
74.03 |
99.79% |
Hom_Normal_Prostate_T1cN0M0_WT_N62_56yrs_Male |
Normal_Prostate_T1cN0M0_WT_N62_56yrs_Male |
Prostate Cancer (T1cN0M0) from 56-year-old male named N62 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.81% |
83.81% |
|
|
67.95 |
99.82% |
Hom_Normal_Prostate_T2bN0M1b_InFrameDel_N63_76yrs_Male |
Normal_Prostate_T2bN0M1b_InFrameDel_N63_76yrs_Male |
Prostate Cancer (T2bN0M1b) from 76-year-old male named N63 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.44% |
85.09% |
|
|
63.02 |
99.39% |
Hom_Normal_Prostate_T3bNAM0_WT_N637_57yrs_Male |
Normal_Prostate_T3bNAM0_WT_N637_57yrs_Male |
Prostate Cancer (T3bNAM0) from 57-year-old male named N637 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.38% |
83.10% |
|
|
67.36 |
99.74% |
Hom_Normal_Prostate_T3NAM0_WT_N638_69yrs_Male |
Normal_Prostate_T3NAM0_WT_N638_69yrs_Male |
Prostate Cancer (T3NAM0) from 69-year-old male named N638 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.06% |
82.99% |
|
|
61.26 |
99.79% |
Hom_Normal_Prostate_T2cN0M0_InFrameDel_N64_66yrs_Male |
Normal_Prostate_T2cN0M0_InFrameDel_N64_66yrs_Male |
Prostate Cancer (T2cN0M0) from 66-year-old male named N64 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.00% |
84.39% |
|
|
75.18 |
99.76% |
Hom_Normal_Prostate_T2aN0M0_WT_N643_68yrs_Male |
Normal_Prostate_T2aN0M0_WT_N643_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named N643 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.28% |
83.78% |
|
|
66.18 |
99.82% |
Hom_Normal_Prostate_NAN0M0_WT_N659_64yrs_Male |
Normal_Prostate_NAN0M0_WT_N659_64yrs_Male |
Prostate Cancer (NAN0M0) from 64-year-old male named N659 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.30% |
84.26% |
|
|
66.40 |
99.62% |
Hom_Normal_Prostate_T3bN1M0_WT_N67_51yrs_Male |
Normal_Prostate_T3bN1M0_WT_N67_51yrs_Male |
Prostate Cancer (T3bN1M0) from 51-year-old male named N67 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.84% |
83.81% |
|
|
74.44 |
99.84% |
Hom_Normal_Prostate_T2cN0M0_WT_N685_74yrs_Male |
Normal_Prostate_T2cN0M0_WT_N685_74yrs_Male |
Prostate Cancer (T2cN0M0) from 74-year-old male named N685 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.30% |
84.18% |
|
|
65.96 |
99.75% |
Hom_Normal_Prostate_T3aN1M1a_WT_N69_75yrs_Male |
Normal_Prostate_T3aN1M1a_WT_N69_75yrs_Male |
Prostate Cancer (T3aN1M1a) from 75-year-old male named N69 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.09% |
83.16% |
|
|
74.58 |
99.76% |
Hom_Normal_Prostate_T1aN0M0_WT_N6_59yrs_Male |
Normal_Prostate_T1aN0M0_WT_N6_59yrs_Male |
Prostate Cancer (T1aN0M0) from 59-year-old male named N6 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.22% |
84.17% |
|
|
84.70 |
99.76% |
Hom_Normal_Prostate_T3cN0M0_WT_N71_61yrs_Male |
Normal_Prostate_T3cN0M0_WT_N71_61yrs_Male |
Prostate Cancer (T3cN0M0) from 61-year-old male named N71 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.23% |
84.65% |
|
|
71.37 |
99.53% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N716_53yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N716_53yrs_Male |
Prostate Cancer (T2aN0M0) from 53-year-old male named N716 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.45% |
83.62% |
|
|
74.60 |
99.84% |
Hom_Normal_Prostate_T2cN0M0_WT_N717_65yrs_Male |
Normal_Prostate_T2cN0M0_WT_N717_65yrs_Male |
Prostate Cancer (T2cN0M0) from 65-year-old male named N717 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.06% |
83.17% |
|
|
70.36 |
99.70% |
Hom_Normal_Prostate_T3aN0M0_WT_N72_72yrs_Male |
Normal_Prostate_T3aN0M0_WT_N72_72yrs_Male |
Prostate Cancer (T3aN0M0) from 72-year-old male named N72 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.94% |
84.55% |
|
|
75.05 |
99.11% |
Hom_Normal_Prostate_T1cN0M0_InFrameDel_N727_60yrs_Male |
Normal_Prostate_T1cN0M0_InFrameDel_N727_60yrs_Male |
Prostate Cancer (T1cN0M0) from 60-year-old male named N727 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.89% |
83.91% |
|
|
63.43 |
99.84% |
Hom_Normal_Prostate_T3aN0M0_InFrameDel_N728_68yrs_Male |
Normal_Prostate_T3aN0M0_InFrameDel_N728_68yrs_Male |
Prostate Cancer (T3aN0M0) from 68-year-old male named N728 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.86% |
82.24% |
|
|
62.76 |
99.64% |
Hom_Normal_Prostate_T3bNxM0_WT_N729_64yrs_Male |
Normal_Prostate_T3bNxM0_WT_N729_64yrs_Male |
Prostate Cancer (T3bNxM0) from 64-year-old male named N729 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.83% |
84.71% |
|
|
74.93 |
99.38% |
Hom_Normal_Prostate_T1cN0M0_WT_N78_74yrs_Male |
Normal_Prostate_T1cN0M0_WT_N78_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named N78 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.71% |
83.86% |
|
|
76.74 |
99.83% |
Hom_Normal_Prostate_T3aN0M0_Frame_Shift_Del_N85_75yrs_Male |
Normal_Prostate_T3aN0M0_Frame_Shift_Del_N85_75yrs_Male |
Prostate Cancer (T3aN0M0) from 75-year-old male named N85 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
89.23% |
84.92% |
|
|
66.02 |
99.66% |
Hom_Normal_Prostate_T2aN0M0_InFrameDel_N92_75yrs_Male |
Normal_Prostate_T2aN0M0_InFrameDel_N92_75yrs_Male |
Prostate Cancer (T2aN0M0) from 75-year-old male named N92 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.22% |
84.69% |
|
|
78.41 |
99.53% |
Hom_Normal_Prostate_T1cN0M0_WT_N96_74yrs_Male |
Normal_Prostate_T1cN0M0_WT_N96_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named N96 with Wide_Type FOXA1 Mutation |
male |
hg38 |
85.36% |
80.65% |
|
|
66.27 |
99.64% |
Hom_Tumor_Prostate_T2bN0M0_WT_T10_65yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T10_65yrs_Male |
Prostate Cancer (T2bN0M0) from 65-year-old male named T10 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.53% |
84.20% |
|
|
77.90 |
99.84% |
Hom_Tumor_Prostate_T2bN0M0_WT_T100_72yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T100_72yrs_Male |
Prostate Cancer (T2bN0M0) from 72-year-old male named T100 with Wide_Type FOXA1 Mutation |
male |
hg38 |
82.43% |
78.11% |
|
|
62.66 |
99.82% |
Hom_Tumor_Prostate_T3bN0M0_WT_T103_68yrs_Male |
Tumor_Prostate_T3bN0M0_WT_T103_68yrs_Male |
Prostate Cancer (T3bN0M0) from 68-year-old male named T103 with Wide_Type FOXA1 Mutation |
male |
hg38 |
79.64% |
75.78% |
|
|
60.25 |
99.82% |
Hom_Tumor_Prostate_T2bN0M0_InFrameDel_T109_66yrs_Male |
Tumor_Prostate_T2bN0M0_InFrameDel_T109_66yrs_Male |
Prostate Cancer (T2bN0M0) from 66-year-old male named T109 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.30% |
82.25% |
|
|
66.03 |
99.80% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T111_74yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T111_74yrs_Male |
Prostate Cancer (T2cN0M0) from 74-year-old male named T111 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.56% |
82.27% |
|
|
66.61 |
99.81% |
Hom_Tumor_Prostate_T3aN0M0_InFrameDel_T113_62yrs_Male |
Tumor_Prostate_T3aN0M0_InFrameDel_T113_62yrs_Male |
Prostate Cancer (T3aN0M0) from 62-year-old male named T113 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
81.95% |
76.39% |
|
|
67.74 |
99.39% |
Hom_Tumor_Prostate_T2cN0M0_WT_T114_75yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T114_75yrs_Male |
Prostate Cancer (T2cN0M0) from 75-year-old male named T114 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.05% |
84.19% |
|
|
76.53 |
99.80% |
Hom_Tumor_Prostate_T1cN0M0_WT_T117_72yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T117_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named T117 with Wide_Type FOXA1 Mutation |
male |
hg38 |
83.11% |
77.79% |
|
|
60.64 |
99.54% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T12_69yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T12_69yrs_Male |
Prostate Cancer (T2cN0M0) from 69-year-old male named T12 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.44% |
85.07% |
|
|
67.68 |
99.85% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T120_68yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T120_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named T120 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.39% |
82.08% |
|
|
71.87 |
99.81% |
Hom_Tumor_Prostate_T1cN0M0_WT_T123_65yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T123_65yrs_Male |
Prostate Cancer (T1cN0M0) from 65-year-old male named T123 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.81% |
84.18% |
|
|
69.34 |
99.82% |
Hom_Tumor_Prostate_T2cN0M0_WT_T124_66yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T124_66yrs_Male |
Prostate Cancer (T2cN0M0) from 66-year-old male named T124 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.52% |
83.88% |
|
|
78.87 |
99.82% |
Hom_Tumor_Prostate_T3bN1M0_WT_T125_74yrs_Male |
Tumor_Prostate_T3bN1M0_WT_T125_74yrs_Male |
Prostate Cancer (T3bN1M0) from 74-year-old male named T125 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.47% |
83.75% |
|
|
77.00 |
99.82% |
Hom_Tumor_Prostate_T2aN0M1b_WT_T131_61yrs_Male |
Tumor_Prostate_T2aN0M1b_WT_T131_61yrs_Male |
Prostate Cancer (T2aN0M1b) from 61-year-old male named T131 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.33% |
84.23% |
|
|
71.75 |
99.84% |
Hom_Tumor_Prostate_T2aN0M0_WT_T132_65yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T132_65yrs_Male |
Prostate Cancer (T2aN0M0) from 65-year-old male named T132 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.95% |
82.78% |
|
|
73.49 |
99.83% |
Hom_Tumor_Prostate_T1cN0M0_Frame_Shift_Del_T133_69yrs_Male |
Tumor_Prostate_T1cN0M0_Frame_Shift_Del_T133_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T133 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
85.70% |
82.06% |
|
|
65.74 |
99.77% |
Hom_Tumor_Prostate_T2cN0M0_WT_T137_68yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T137_68yrs_Male |
Prostate Cancer (T2cN0M0) from 68-year-old male named T137 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.16% |
83.41% |
|
|
67.38 |
99.77% |
Hom_Tumor_Prostate_T3bN0M0_MissenseMutation_T139_78yrs_Male |
Tumor_Prostate_T3bN0M0_MissenseMutation_T139_78yrs_Male |
Prostate Cancer (T3bN0M0) from 78-year-old male named T139 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.67% |
83.45% |
|
|
70.34 |
99.79% |
Hom_Tumor_Prostate_T2aN0M0_WT_T143_74yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T143_74yrs_Male |
Prostate Cancer (T2aN0M0) from 74-year-old male named T143 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.70% |
83.65% |
|
|
66.36 |
99.81% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T157_69yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T157_69yrs_Male |
Prostate Cancer (T2aN0M0) from 69-year-old male named T157 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
83.66% |
79.03% |
|
|
66.88 |
99.29% |
Hom_Tumor_Prostate_T2bN0M0_WT_T16_67yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T16_67yrs_Male |
Prostate Cancer (T2bN0M0) from 67-year-old male named T16 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.85% |
85.05% |
|
|
69.67 |
99.83% |
Hom_Tumor_Prostate_T1cN0M0_WT_T160_72yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T160_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named T160 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.06% |
82.03% |
|
|
69.56 |
99.84% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T162_60yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T162_60yrs_Male |
Prostate Cancer (T1cN0M0) from 60-year-old male named T162 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.19% |
83.31% |
|
|
74.08 |
99.85% |
Hom_Tumor_Prostate_T3bN1M1c_WT_T166_67yrs_Male |
Tumor_Prostate_T3bN1M1c_WT_T166_67yrs_Male |
Prostate Cancer (T3bN1M1c) from 67-year-old male named T166 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.23% |
83.20% |
|
|
72.31 |
99.82% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T167_74yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T167_74yrs_Male |
Prostate Cancer (T2cN0M0) from 74-year-old male named T167 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.06% |
84.14% |
|
|
68.99 |
99.82% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T17_61yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T17_61yrs_Male |
Prostate Cancer (T2cN0M0) from 61-year-old male named T17 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.18% |
83.17% |
|
|
70.51 |
99.81% |
Hom_Tumor_Prostate_T3aN0M0_WT_T172_67yrs_Male |
Tumor_Prostate_T3aN0M0_WT_T172_67yrs_Male |
Prostate Cancer (T3aN0M0) from 67-year-old male named T172 with Wide_Type FOXA1 Mutation |
male |
hg38 |
90.02% |
86.02% |
|
|
70.25 |
99.83% |
Hom_Tumor_Prostate_T3bN0M1b_InFrameDel_T174_68yrs_Male |
Tumor_Prostate_T3bN0M1b_InFrameDel_T174_68yrs_Male |
Prostate Cancer (T3bN0M1b) from 68-year-old male named T174 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
90.03% |
85.58% |
|
|
72.44 |
99.81% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T176_69yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T176_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T176 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
86.82% |
82.39% |
|
|
67.37 |
99.79% |
Hom_Tumor_Prostate_T2N0M0_WT_T178_65yrs_Male |
Tumor_Prostate_T2N0M0_WT_T178_65yrs_Male |
Prostate Cancer (T2N0M0) from 65-year-old male named T178 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.00% |
84.86% |
|
|
81.13 |
99.69% |
Hom_Tumor_Prostate_T2bN0Mx_WT_T18_65yrs_Male |
Tumor_Prostate_T2bN0Mx_WT_T18_65yrs_Male |
Prostate Cancer (T2bN0Mx) from 65-year-old male named T18 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.83% |
84.41% |
|
|
60.63 |
99.71% |
Hom_Tumor_Prostate_T1cN0M0_Frame_Shift_Del_T182_76yrs_Male |
Tumor_Prostate_T1cN0M0_Frame_Shift_Del_T182_76yrs_Male |
Prostate Cancer (T1cN0M0) from 76-year-old male named T182 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
88.94% |
85.33% |
|
|
81.72 |
99.72% |
Hom_Tumor_Prostate_T2cN0M1b_WT_T185_64yrs_Male |
Tumor_Prostate_T2cN0M1b_WT_T185_64yrs_Male |
Prostate Cancer (T2cN0M1b) from 64-year-old male named T185 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.79% |
84.95% |
|
|
60.27 |
99.70% |
Hom_Tumor_Prostate_T1cN0M0_WT_T186_69yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T186_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T186 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.83% |
86.37% |
|
|
75.90 |
99.71% |
Hom_Tumor_Prostate_T1cN0M0_WT_T19_75yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T19_75yrs_Male |
Prostate Cancer (T1cN0M0) from 75-year-old male named T19 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.47% |
84.05% |
|
|
72.72 |
99.76% |
Hom_Tumor_Prostate_T2bN0M0_WT_T196_59yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T196_59yrs_Male |
Prostate Cancer (T2bN0M0) from 59-year-old male named T196 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.83% |
84.75% |
|
|
71.70 |
99.76% |
Hom_Tumor_Prostate_T1cN0M0_WT_T198_67yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T198_67yrs_Male |
Prostate Cancer (T1cN0M0) from 67-year-old male named T198 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.19% |
83.47% |
|
|
64.90 |
99.68% |
Hom_Tumor_Prostate_T3aN0M0_MissenseMutation_T1_70yrs_Male |
Tumor_Prostate_T3aN0M0_MissenseMutation_T1_70yrs_Male |
Prostate Cancer (T3aN0M0) from 70-year-old male named T1 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
88.89% |
84.26% |
|
|
67.78 |
99.80% |
Hom_Tumor_Prostate_T3aN1M0_WT_T201_55yrs_Male |
Tumor_Prostate_T3aN1M0_WT_T201_55yrs_Male |
Prostate Cancer (T3aN1M0) from 55-year-old male named T201 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.48% |
82.85% |
|
|
69.80 |
99.77% |
Hom_Tumor_Prostate_T2aN0M0_MissenseMutation_T202_70yrs_Male |
Tumor_Prostate_T2aN0M0_MissenseMutation_T202_70yrs_Male |
Prostate Cancer (T2aN0M0) from 70-year-old male named T202 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.48% |
84.11% |
|
|
70.42 |
99.77% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T208_71yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T208_71yrs_Male |
Prostate Cancer (T2cN0M0) from 71-year-old male named T208 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
89.31% |
84.96% |
|
|
69.74 |
99.56% |
Hom_Tumor_Prostate_T2aN0M0_WT_T209_62yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T209_62yrs_Male |
Prostate Cancer (T2aN0M0) from 62-year-old male named T209 with Wide_Type FOXA1 Mutation |
male |
hg38 |
86.12% |
81.95% |
|
|
73.82 |
99.80% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T210_74yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T210_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named T210 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
89.28% |
85.82% |
|
|
68.96 |
99.81% |
Hom_Tumor_Prostate_T2cN1M1b_InFrameDel_T211_71yrs_Male |
Tumor_Prostate_T2cN1M1b_InFrameDel_T211_71yrs_Male |
Prostate Cancer (T2cN1M1b) from 71-year-old male named T211 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.29% |
84.47% |
|
|
74.92 |
99.77% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T213_69yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T213_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T213 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
80.08% |
74.11% |
|
|
63.03 |
99.30% |
Hom_Tumor_Prostate_T2aN0M0_MissenseMutation_T215_64yrs_Male |
Tumor_Prostate_T2aN0M0_MissenseMutation_T215_64yrs_Male |
Prostate Cancer (T2aN0M0) from 64-year-old male named T215 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.64% |
83.67% |
|
|
64.57 |
99.67% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T216_68yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T216_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named T216 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.11% |
83.06% |
|
|
85.93 |
99.74% |
Hom_Tumor_Prostate_T3aN1M0_WT_T217_79yrs_Male |
Tumor_Prostate_T3aN1M0_WT_T217_79yrs_Male |
Prostate Cancer (T3aN1M0) from 79-year-old male named T217 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.02% |
85.52% |
|
|
65.15 |
99.56% |
Hom_Tumor_Prostate_T2aN0M0_WT_T22_76yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T22_76yrs_Male |
Prostate Cancer (T2aN0M0) from 76-year-old male named T22 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.22% |
84.28% |
|
|
71.31 |
99.79% |
Hom_Tumor_Prostate_T1cN0M0_WT_T229_69yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T229_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T229 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.14% |
84.42% |
|
|
63.76 |
99.75% |
Hom_Tumor_Prostate_T2aN0M0_WT_T231_74yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T231_74yrs_Male |
Prostate Cancer (T2aN0M0) from 74-year-old male named T231 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.52% |
83.67% |
|
|
77.66 |
99.61% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T232_70yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T232_70yrs_Male |
Prostate Cancer (T2aN0M0) from 70-year-old male named T232 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.88% |
83.40% |
|
|
64.56 |
99.78% |
Hom_Tumor_Prostate_T1aN0M1b_WT_T236_75yrs_Male |
Tumor_Prostate_T1aN0M1b_WT_T236_75yrs_Male |
Prostate Cancer (T1aN0M1b) from 75-year-old male named T236 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.18% |
85.16% |
|
|
60.25 |
99.52% |
Hom_Tumor_Prostate_T2aN0M0_WT_T251_66yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T251_66yrs_Male |
Prostate Cancer (T2aN0M0) from 66-year-old male named T251 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.28% |
84.20% |
|
|
76.40 |
99.50% |
Hom_Tumor_Prostate_T2aN0M0_WT_T258_68yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T258_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named T258 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.50% |
84.23% |
|
|
74.06 |
99.71% |
Hom_Tumor_Prostate_T2bN0M0_MissenseMutation_T26_67yrs_Male |
Tumor_Prostate_T2bN0M0_MissenseMutation_T26_67yrs_Male |
Prostate Cancer (T2bN0M0) from 67-year-old male named T26 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
88.48% |
84.36% |
|
|
85.16 |
99.71% |
Hom_Tumor_Prostate_T3aN0M0_WT_T268_61yrs_Male |
Tumor_Prostate_T3aN0M0_WT_T268_61yrs_Male |
Prostate Cancer (T3aN0M0) from 61-year-old male named T268 with Wide_Type FOXA1 Mutation |
male |
hg38 |
83.90% |
79.92% |
|
|
70.01 |
99.61% |
Hom_Tumor_Prostate_T2bN0M0_MissenseMutation_T271_69yrs_Male |
Tumor_Prostate_T2bN0M0_MissenseMutation_T271_69yrs_Male |
Prostate Cancer (T2bN0M0) from 69-year-old male named T271 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
89.67% |
85.32% |
|
|
78.35 |
99.77% |
Hom_Tumor_Prostate_T1bN0M0_WT_T265_64yrs_Male |
Tumor_Prostate_T1bN0M0_WT_T265_64yrs_Male |
Prostate Cancer (T1bN0M0) from 64-year-old male named T265 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.25% |
84.46% |
|
|
80.92 |
99.78% |
Hom_Tumor_Prostate_T1bN0M0_WT_T273_72yrs_Male |
Tumor_Prostate_T1bN0M0_WT_T273_72yrs_Male |
Prostate Cancer (T1bN0M0) from 72-year-old male named T273 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.56% |
84.47% |
|
|
82.56 |
99.83% |
Hom_Tumor_Prostate_NANANA_NA_T274_NAyrs_Male |
Tumor_Prostate_NANANA_NA_T274_NAyrs_Male |
Prostate Cancer (NANANA) from NA-year-old male named T274 with NA FOXA1 Mutation |
male |
hg38 |
87.45% |
83.34% |
|
|
68.76 |
99.48% |
Hom_Tumor_Prostate_T2cN0M0_WT_T279_78yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T279_78yrs_Male |
Prostate Cancer (T2cN0M0) from 78-year-old male named T279 with Wide_Type FOXA1 Mutation |
male |
hg38 |
82.33% |
78.64% |
|
|
81.71 |
99.83% |
Hom_Tumor_Prostate_T3bN1M1a_Frame_Shift_Del_T28_68yrs_Male |
Tumor_Prostate_T3bN1M1a_Frame_Shift_Del_T28_68yrs_Male |
Prostate Cancer (T3bN1M1a) from 68-year-old male named T28 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
88.75% |
84.50% |
|
|
73.64 |
99.77% |
Hom_Tumor_Prostate_T2aN0M0_WT_T283_62yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T283_62yrs_Male |
Prostate Cancer (T2aN0M0) from 62-year-old male named T283 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.06% |
84.60% |
|
|
71.43 |
99.62% |
Hom_Tumor_Prostate_T3bN1M0_WT_T286_71yrs_Male |
Tumor_Prostate_T3bN1M0_WT_T286_71yrs_Male |
Prostate Cancer (T3bN1M0) from 71-year-old male named T286 with Wide_Type FOXA1 Mutation |
male |
hg38 |
89.28% |
85.08% |
|
|
72.02 |
99.85% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T289_64yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T289_64yrs_Male |
Prostate Cancer (T2aN0M0) from 64-year-old male named T289 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
90.22% |
86.34% |
|
|
61.12 |
99.74% |
Hom_Tumor_Prostate_T2bN0M0_WT_T294_54yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T294_54yrs_Male |
Prostate Cancer (T2bN0M0) from 54-year-old male named T294 with Wide_Type FOXA1 Mutation |
male |
hg38 |
90.42% |
86.39% |
|
|
68.41 |
99.68% |
Hom_Tumor_Prostate_T3aN0M0_InFrameDel_T300_71yrs_Male |
Tumor_Prostate_T3aN0M0_InFrameDel_T300_71yrs_Male |
Prostate Cancer (T3aN0M0) from 71-year-old male named T300 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
90.59% |
86.67% |
|
|
69.07 |
99.69% |
Hom_Tumor_Prostate_T1bN0M0_InFrameDel_T312_64yrs_Male |
Tumor_Prostate_T1bN0M0_InFrameDel_T312_64yrs_Male |
Prostate Cancer (T1bN0M0) from 64-year-old male named T312 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
83.97% |
80.48% |
|
|
74.22 |
99.75% |
Hom_Tumor_Prostate_T1cN0M0_WT_T313_62yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T313_62yrs_Male |
Prostate Cancer (T1cN0M0) from 62-year-old male named T313 with Wide_Type FOXA1 Mutation |
male |
hg38 |
85.27% |
81.19% |
|
|
66.01 |
99.86% |
Hom_Tumor_Prostate_T1cN0M0_WT_T314_64yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T314_64yrs_Male |
Prostate Cancer (T1cN0M0) from 64-year-old male named T314 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.63% |
84.51% |
|
|
80.31 |
99.35% |
Hom_Tumor_Prostate_T2cN0M0_Frame_Shift_Del_T315_78yrs_Male |
Tumor_Prostate_T2cN0M0_Frame_Shift_Del_T315_78yrs_Male |
Prostate Cancer (T2cN0M0) from 78-year-old male named T315 with Frame_Shift_Del FOXA1 Mutation |
male |
hg38 |
81.38% |
76.30% |
|
|
69.62 |
99.54% |
Hom_Tumor_Prostate_T2cN0M0_WT_T318_78yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T318_78yrs_Male |
Prostate Cancer (T2cN0M0) from 78-year-old male named T318 with Wide_Type FOXA1 Mutation |
male |
hg38 |
87.23% |
83.14% |
|
|
72.11 |
99.09% |
Hom_Tumor_Prostate_T2aN0M0_WT_T319_69yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T319_69yrs_Male |
Prostate Cancer (T2aN0M0) from 69-year-old male named T319 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.30% |
83.95% |
|
|
70.90 |
99.70% |
Hom_Tumor_Prostate_T3aNXM0_InFrameDel_T31_66yrs_Male |
Tumor_Prostate_T3aNXM0_InFrameDel_T31_66yrs_Male |
Prostate Cancer (T3aNXM0) from 66-year-old male named T31 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
88.66% |
84.50% |
|
|
79.31 |
99.78% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T321_73yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T321_73yrs_Male |
Prostate Cancer (T1cN0M0) from 73-year-old male named T321 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
87.70% |
83.67% |
|
|
76.10 |
99.74% |
Hom_Tumor_Prostate_T2cN0M0_MissenseMutation_T325_76yrs_Male |
Tumor_Prostate_T2cN0M0_MissenseMutation_T325_76yrs_Male |
Prostate Cancer (T2cN0M0) from 76-year-old male named T325 with Missense_Mutation FOXA1 Mutation |
male |
hg38 |
86.61% |
82.91% |
|
|
82.75 |
99.71% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T326_63yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T326_63yrs_Male |
Prostate Cancer (T2aN0M0) from 63-year-old male named T326 with In_Frame_Del FOXA1 Mutation |
male |
hg38 |
87.56% |
83.30% |
|
|
75.34 |
99.73% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T329_71yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T329_71yrs_Male |
Prostate Cancer (T1cN0M0) from 71-year-old male named T329 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
90.22% |
85.50% |
|
|
67.25 |
99.61% |
Hom_Tumor_Prostate_T1cN0M0_WT_T32_88yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T32_88yrs_Male |
Prostate Cancer (T1cN0M0) from 88-year-old male named T32 with Wide_Type FOXA1 Mutation |
male |
hg38 |
88.78% |
84.88% |
|
|
74.48 |
99.82% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T330_70yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T330_70yrs_Male |
Prostate Cancer (T2cN0M0) from 70-year-old male named T330 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
88.64% |
83.48% |
|
|
100.29 |
99.49% |
Hom_Tumor_Prostate_T2aN0M0_WT_T331_74yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T331_74yrs_Male |
Prostate Cancer (T2aN0M0) from 74-year-old male named T331 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.39% |
85.30% |
|
|
73.09 |
99.73% |
Hom_Tumor_Prostate_T0N0M0_WT_T332_68yrs_Male |
Tumor_Prostate_T0N0M0_WT_T332_68yrs_Male |
Prostate Cancer (T0N0M0) from 68-year-old male named T332 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.25% |
85.16% |
|
|
84.34 |
99.82% |
Hom_Tumor_Prostate_T2cN0M0_WT_T334_79yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T334_79yrs_Male |
Prostate Cancer (T2cN0M0) from 79-year-old male named T334 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.07% |
84.62% |
|
|
74.95 |
99.84% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T335_64yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T335_64yrs_Male |
Prostate Cancer (T1cN0M0) from 64-year-old male named T335 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
87.96% |
83.69% |
|
|
70.83 |
99.84% |
Hom_Tumor_Prostate_T2bN0M0_FrameShiftDel_T339_66yrs_Male |
Tumor_Prostate_T2bN0M0_FrameShiftDel_T339_66yrs_Male |
Prostate Cancer (T2bN0M0) from 66-year-old male named T339 with Frame_Shift_Del FOXA1 Mutation |
Male |
hg38 |
89.52% |
85.14% |
|
|
70.60 |
99.62% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T340_78yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T340_78yrs_Male |
Prostate Cancer (T2cN0M0) from 78-year-old male named T340 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.73% |
84.87% |
|
|
70.49 |
99.61% |
Hom_Tumor_Prostate_T3bN1M0_WT_T342_71yrs_Male |
Tumor_Prostate_T3bN1M0_WT_T342_71yrs_Male |
Prostate Cancer (T3bN1M0) from 71-year-old male named T342 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.94% |
85.91% |
|
|
80.57 |
99.70% |
Hom_Tumor_Prostate_T2cN0M0_MissenseMutation_T349_73yrs_Male |
Tumor_Prostate_T2cN0M0_MissenseMutation_T349_73yrs_Male |
Prostate Cancer (T2cN0M0) from 73-year-old male named T349 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
89.17% |
85.27% |
|
|
79.31 |
99.76% |
Hom_Tumor_Prostate_T2aN0M0_WT_T34_64yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T34_64yrs_Male |
Prostate Cancer (T2aN0M0) from 64-year-old male named T34 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.02% |
82.62% |
|
|
79.27 |
99.75% |
Hom_Tumor_Prostate_T2bN0M0_InFrameDel_T358_68yrs_Male |
Tumor_Prostate_T2bN0M0_InFrameDel_T358_68yrs_Male |
Prostate Cancer (T2bN0M0) from 68-year-old male named T358 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.95% |
85.45% |
|
|
67.27 |
99.80% |
Hom_Tumor_Prostate_T2aN0M1b_InFrameDel_T36_77yrs_Male |
Tumor_Prostate_T2aN0M1b_InFrameDel_T36_77yrs_Male |
Prostate Cancer (T2aN0M1b) from 77-year-old male named T36 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
86.00% |
82.60% |
|
|
64.13 |
99.81% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T361_60yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T361_60yrs_Male |
Prostate Cancer (T1cN0M0) from 60-year-old male named T361 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.95% |
85.22% |
|
|
65.01 |
99.84% |
Hom_Tumor_Prostate_T1aN0M0_WT_T367_62yrs_Male |
Tumor_Prostate_T1aN0M0_WT_T367_62yrs_Male |
Prostate Cancer (T1aN0M0) from 62-year-old male named T367 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.87% |
85.63% |
|
|
61.99 |
99.84% |
Hom_Tumor_Prostate_T2cN0M0_WT_T373_61yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T373_61yrs_Male |
Prostate Cancer (T2cN0M0) from 61-year-old male named T373 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.81% |
86.27% |
|
|
82.04 |
99.84% |
Hom_Tumor_Prostate_T2cN0M0_WT_T375_66yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T375_66yrs_Male |
Prostate Cancer (T2cN0M0) from 66-year-old male named T375 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.71% |
84.00% |
|
|
68.89 |
99.80% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T378_73yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T378_73yrs_Male |
Prostate Cancer (T1cN0M0) from 73-year-old male named T378 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.27% |
84.97% |
|
|
67.39 |
99.81% |
Hom_Tumor_Prostate_T2bN0M0_WT_T379_80yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T379_80yrs_Male |
Prostate Cancer (T2bN0M0) from 80-year-old male named T379 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.92% |
83.06% |
|
|
61.18 |
99.72% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T380_69yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T380_69yrs_Male |
Prostate Cancer (T1cN0M0) from 69-year-old male named T380 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
90.00% |
86.09% |
|
|
70.97 |
99.84% |
Hom_Tumor_Prostate_T2bN0M0_WT_T384_64yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T384_64yrs_Male |
Prostate Cancer (2bN0M0) from 64-year-old male named T384 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.58% |
85.83% |
|
|
60.37 |
99.49% |
Hom_Tumor_Prostate_T1cN0M0_WT_T385_58yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T385_58yrs_Male |
Prostate Cancer (T1cN0M0) from 58-year-old male named T385 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.69% |
84.58% |
|
|
72.05 |
99.42% |
Hom_Tumor_Prostate_T3aN0M0_WT_T389_74yrs_Male |
Tumor_Prostate_T3aN0M0_WT_T389_74yrs_Male |
Prostate Cancer (T3aN0M0) from 74-year-old male named T389 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.24% |
83.12% |
|
|
67.40 |
99.71% |
Hom_Tumor_Prostate_T2aN0M0_WT_T391_64yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T391_64yrs_Male |
Prostate Cancer (T2aN0M0) from 64-year-old male named T391 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.03% |
83.20% |
|
|
63.51 |
99.79% |
Hom_Tumor_Prostate_T1bN0M0_WT_T393_67yrs_Male |
Tumor_Prostate_T1bN0M0_WT_T393_67yrs_Male |
Prostate Cancer (T1bN0M0) from 67-year-old male named T393 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.56% |
84.41% |
|
|
67.64 |
99.79% |
Hom_Tumor_Prostate_T1cN0M0_WT_T396_58yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T396_58yrs_Male |
Prostate Cancer (T1cN0M0) from 58-year-old male named T396 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.70% |
83.58% |
|
|
73.15 |
99.83% |
Hom_Tumor_Prostate_T1cN0M0_WT_T405_67yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T405_67yrs_Male |
Prostate Cancer (T1cN0M0) from 67-year-old male named T67 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.00% |
84.53% |
|
|
73.46 |
|
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T408_78yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T408_78yrs_Male |
Prostate Cancer (T2aN0M0) from 78-year-old male named T408 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.30% |
84.95% |
|
|
60.51 |
99.42% |
Hom_Tumor_Prostate_T2cN0Mx_InFrameDel_T410_80yrs_Male |
Tumor_Prostate_T2cN0Mx_InFrameDel_T410_80yrs_Male |
Prostate Cancer (T2cN0Mx) from 80-year-old male named T410 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
88.69% |
85.19% |
|
|
65.34 |
99.68% |
Hom_Tumor_Prostate_T2aN0Mx_WT_T411_63yrs_Male |
Tumor_Prostate_T2aN0Mx_WT_T411_63yrs_Male |
Prostate Cancer (T2aN0Mx) from 63-year-old male named T411 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.22% |
86.44% |
|
|
72.02 |
99.78% |
Hom_Tumor_Prostate_T2bN1M0_WT_T42_68yrs_Male |
Tumor_Prostate_T2bN1M0_WT_T42_68yrs_Male |
Prostate Cancer (T2bN1M0) from 68-year-old male named T42 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.13% |
84.62% |
|
|
78.16 |
99.75% |
Hom_Tumor_Prostate_T2cN0M0_WT_T43_72yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T43_72yrs_Male |
Prostate Cancer (T2cN0M0) from 72-year-old male named T43 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.08% |
85.14% |
|
|
70.46 |
99.81% |
Hom_Tumor_Prostate_T1cN0M0_WT_T431_61yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T431_61yrs_Male |
Prostate Cancer (T1cN0M0) from 61-year-old male named T431 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.33% |
83.99% |
|
|
67.36 |
99.81% |
Hom_Tumor_Prostate_T2aN0M0_WT_T434_69yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T434_69yrs_Male |
Prostate Cancer (T2aN0M0) from 69-year-old male named T434 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.32% |
82.88% |
|
|
61.49 |
99.79% |
Hom_Tumor_Prostate_T2bN0M0_WT_T465_80yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T465_80yrs_Male |
Prostate Cancer (T2bN0M0) from 80-year-old male named T465 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
85.37% |
80.97% |
|
|
63.60 |
99.46% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T467_56yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T467_56yrs_Male |
Prostate Cancer (T2cN0M0) from 56-year-old male named T467 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
87.59% |
84.13% |
|
|
68.04 |
99.80% |
Hom_Tumor_Prostate_T2cN0M0_WT_T47_70yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T47_70yrs_Male |
Prostate Cancer (T2cN0M0) from 70-year-old male named T47 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.41% |
84.44% |
|
|
67.27 |
99.44% |
Hom_Tumor_Prostate_T2aN0M0_FrameShiftIns_T471_70yrs_Male |
Tumor_Prostate_T2aN0M0_FrameShiftIns_T471_70yrs_Male |
Prostate Cancer (T2aN0M0) from 70-year-old male named T471 with Frame_Shift_Ins FOXA1 Mutation |
Male |
hg38 |
84.94% |
80.80% |
|
|
68.44 |
99.55% |
Hom_Tumor_Prostate_T2aN0M0_WT_T473_59yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T473_59yrs_Male |
Prostate Cancer (T2aN0M0) from 59-year-old male named T473 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
85.73% |
81.81% |
|
|
68.82 |
99.38% |
Hom_Tumor_Prostate_T1cN1M0_WT_T476_55yrs_Male |
Tumor_Prostate_T1cN1M0_WT_T476_55yrs_Male |
Prostate Cancer (T1cN1M0) from 55-year-old male named T476 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.72% |
84.13% |
|
|
62.74 |
99.80% |
Hom_Tumor_Prostate_T2bN1M0_WT_T477_73yrs_Male |
Tumor_Prostate_T2bN1M0_WT_T477_73yrs_Male |
Prostate Cancer (T2bN1M0) from 73-year-old male named T477 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.93% |
85.00% |
|
|
73.58 |
99.62% |
Hom_Tumor_Prostate_T2bN0M0_FrameShiftDel_T480_76yrs_Male |
Tumor_Prostate_T2bN0M0_FrameShiftDel_T480_76yrs_Male |
Prostate Cancer (T2bN0M0) from 76-year-old male named T480 with Frame_Shift_Ins FOXA1 Mutation |
Male |
hg38 |
85.86% |
82.25% |
|
|
67.17 |
99.76% |
Hom_Tumor_Prostate_T1cN0M0_FrameShiftDel_T482_77yrs_Male |
Tumor_Prostate_T1cN0M0_FrameShiftDel_T482_77yrs_Male |
Prostate Cancer (T1cN0M0) from 77-year-old male named T482 with Frame_Shift_Ins FOXA1 Mutation |
Male |
hg38 |
88.77% |
84.47% |
|
|
63.58 |
99.79% |
Hom_Tumor_Prostate_NAN0M1b_WT_T487_82yrs_Male |
Tumor_Prostate_NAN0M1b_WT_T487_82yrs_Male |
Prostate Cancer (NAN0M1b) from 82-year-old male named T487 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.05% |
84.91% |
|
|
75.08 |
99.81% |
Hom_Tumor_Prostate_T2cN1M1b_WT_T491_71yrs_Male |
Tumor_Prostate_T2cN1M1b_WT_T491_71yrs_Male |
Prostate Cancer (T2cN1M1b) from 71-year-old male named T491 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.70% |
84.58% |
|
|
69.99 |
99.69% |
Hom_Tumor_Prostate_T3bN0M0_WT_T496_66yrs_Male |
Tumor_Prostate_T3bN0M0_WT_T496_66yrs_Male |
Prostate Cancer (T3bN0M0) from 66-year-old male named T496 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.61% |
84.86% |
|
|
61.95 |
99.44% |
Hom_Tumor_Prostate_T1cN0M0_WT_T498_65yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T498_65yrs_Male |
Prostate Cancer (T1cN0M0) from 65-year-old male named T498 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.17% |
83.38% |
|
|
76.65 |
99.80% |
Hom_Tumor_Prostate_T3bN0M1b_WT_T502_62yrs_Male |
Tumor_Prostate_T3bN0M1b_WT_T502_62yrs_Male |
Prostate Cancer (T3bN0M1b) from 62-year-old male named T502 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.11% |
83.43% |
|
|
78.54 |
99.83% |
Hom_Tumor_Prostate_T2N0M0_MissenseMutation_T508_71yrs_Male |
Tumor_Prostate_T2N0M0_MissenseMutation_T508_71yrs_Male |
Prostate Cancer (T2N0M0) from 71-year-old male named T508 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
88.98% |
84.77% |
|
|
69.00 |
99.79% |
Hom_Tumor_Prostate_T2N0M0_WT_T502_70yrs_Male |
Tumor_Prostate_T2N0M0_WT_T502_70yrs_Male |
Prostate Cancer (T2N0M0) from 70-year-old male named T502 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.28% |
82.17% |
|
|
97.02 |
99.78% |
Hom_Tumor_Prostate_T1cN0M0_WT_T50_78yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T50_78yrs_Male |
Prostate Cancer (T1cN0M0) from 78-year-old male named T50 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.80% |
84.87% |
|
|
69.15 |
99.78% |
Hom_Tumor_Prostate_T1cN0M0_WT_T512_68yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T512_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named T512 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.53% |
84.74% |
|
|
75.39 |
99.56% |
Hom_Tumor_Prostate_T1cN0M1b_WT_T513_78yrs_Male |
Tumor_Prostate_T1cN0M1b_WT_T513_78yrs_Male |
Prostate Cancer (T1cN0M1b) from 78-year-old male named T513 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.11% |
81.77% |
|
|
81.05 |
99.69% |
Hom_Tumor_Prostate_T1cN0M0_WT_T515_70yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T515_70yrs_Male |
Prostate Cancer (T1cN0M0) from 70-year-old male named T515 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.64% |
82.64% |
|
|
70.84 |
99.85% |
Hom_Tumor_Prostate_T1cN0M0_WT_T52_64yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T52_64yrs_Male |
Prostate Cancer (T1cN0M0) from 64-year-old male named T52 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.50% |
84.17% |
|
|
65.94 |
99.70% |
Hom_Tumor_Prostate_T2aN0Mx_NonsenseMutation_T521_61yrs_Male |
Tumor_Prostate_T2aN0Mx_NonsenseMutation_T521_61yrs_Male |
Prostate Cancer (T2aN0Mx) from 61-year-old male named T521 with FOXA1 Nonsense_Mutation |
Male |
hg38 |
89.43% |
85.30% |
|
|
77.27 |
99.83% |
Hom_Tumor_Prostate_T2cN0M0_MissenseMutation_T53_65yrs_Male |
Tumor_Prostate_T2cN0M0_MissenseMutation_T53_65yrs_Male |
Prostate Cancer (T2cN0M0) from 65-year-old male named T53 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
88.33% |
84.44% |
|
|
77.77 |
99.80% |
Hom_Tumor_Prostate_T2bN0M0_WT_T54_67yrs_Male |
Tumor_Prostate_T2bN0M0_WT_T54_67yrs_Male |
Prostate Cancer (T2bN0M0) from 67-year-old male named T54 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.73% |
86.52% |
|
|
76.90 |
99.82% |
Hom_Tumor_Prostate_T2N0M0_WT_T546_71yrs_Male |
Tumor_Prostate_T2N0M0_WT_T546_71yrs_Male |
Prostate Cancer (T2N0M0) from 71-year-old male named T546 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.11% |
82.58% |
|
|
70.24 |
99.88% |
Hom_Tumor_Prostate_T2aN0M0_WT_T551_78yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T551_78yrs_Male |
Prostate Cancer (T2aN0M0) from 78-year-old male named T551 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.27% |
83.52% |
|
|
69.63 |
99.85% |
Hom_Tumor_Prostate_T2aN0M0_WT_T556_73yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T556_73yrs_Male |
Prostate Cancer (T2aN0M0) from 73-year-old male named T556 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.84% |
84.42% |
|
|
102.54 |
99.69% |
Hom_Tumor_Prostate_T2aN0Mx_InFrameDel_T558_74yrs_Male |
Tumor_Prostate_T2aN0Mx_InFrameDel_T558_74yrs_Male |
Prostate Cancer (T2aN0Mx) from 74-year-old male named T558 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
87.76% |
83.08% |
|
|
84.35 |
99.26% |
Hom_Tumor_Prostate_T2cN0M0_MissenseMutation_T56_75yrs_Male |
Tumor_Prostate_T2cN0M0_MissenseMutation_T56_75yrs_Male |
Prostate Cancer (T2cN0M0) from 75-year-old male named T56 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
89.07% |
85.34% |
|
|
66.84 |
99.80% |
Hom_Tumor_Prostate_T2aN0Mx_Missense_Mutation_T563_67yrs_Male |
Tumor_Prostate_T2aN0Mx_Missense_Mutation_T563_67yrs_Male |
Prostate Cancer (T2aN0Mx) from 67-year-old male named T563 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
87.82% |
83.03% |
|
|
71.25 |
99.51% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T565_66yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T565_66yrs_Male |
Prostate Cancer (T1cN0M0) from 66-year-old male named T565 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
89.23% |
84.63% |
|
|
79.34 |
99.68% |
Hom_Tumor_Prostate_T2cN0M0_WT_T574_79yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T574_79yrs_Male |
Prostate Cancer (T2cN0M0) from 79-year-old male named T574 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
85.28% |
81.01% |
|
|
66.95 |
99.79% |
Hom_Tumor_Prostate_T1cN0M0_MissenseMutation_T576_68yrs_Male |
Tumor_Prostate_T1cN0M0_MissenseMutation_T576_68yrs_Male |
Prostate Cancer (T1cN0M0) from 68-year-old male named T576 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
88.51% |
84.07% |
|
|
70.58 |
99.13% |
Hom_Tumor_Prostate_T1cN0M0_WT_T577_74yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T577_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named T577 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.46% |
85.30% |
|
|
62.60 |
99.50% |
Hom_Tumor_Prostate_T2cN0M0_WT_T578_79yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T578_79yrs_Male |
Prostate Cancer (T2cN0M0) from 79-year-old male named T578 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.68% |
85.22% |
|
|
103.30 |
99.38% |
Hom_Tumor_Prostate_T2cN0M0_MissenseMutation_T57_72yrs_Male |
Tumor_Prostate_T2cN0M0_MissenseMutation_T57_72yrs_Male |
Prostate Cancer (T2cN0M0) from 72-year-old male named T57 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
90.05% |
85.58% |
|
|
85.70 |
99.56% |
Hom_Tumor_Prostate_T2cN1M0_WT_T585_79yrs_Male |
Tumor_Prostate_T2cN1M0_WT_T585_79yrs_Male |
Prostate Cancer (T2cN1M0) from 79-year-old male named T585 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.89% |
84.06% |
|
|
63.10 |
99.79% |
Hom_Tumor_Prostate_T2aN0M0_MissenseMutation_T587_76yrs_Male |
Tumor_Prostate_T2aN0M0_MissenseMutation_T587_76yrs_Male |
Prostate Cancer (T2aN0M0) from 76-year-old male named T587 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
88.44% |
84.26% |
|
|
88.55 |
99.86% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T58_69yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T58_69yrs_Male |
Prostate Cancer (T2aN0M0) from 69-year-old male named T58 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.96% |
85.85% |
|
|
75.86 |
99.61% |
Hom_Tumor_Prostate_T1cN0M0_Missense_Mutation_T592_72yrs_Male |
Tumor_Prostate_T1cN0M0_Missense_Mutation_T592_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named T592 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
87.56% |
83.03% |
|
|
69.36 |
99.74% |
Hom_Tumor_Prostate_T2aN0M0_WT_T595_68yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T595_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named T595 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.77% |
85.02% |
|
|
86.32 |
99.85% |
Hom_Tumor_Prostate_T2aN0M0_WT_T597_66yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T597_66yrs_Male |
Prostate Cancer (T2aN0M0) from 66-year-old male named T597 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
82.69% |
78.73% |
|
|
67.66 |
99.82% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T600_72yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T600_72yrs_Male |
Prostate Cancer (T1cN0M0) from 72-year-old male named T600 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.92% |
85.19% |
|
|
70.31 |
99.83% |
Hom_Tumor_Prostate_T3bN0M0_WT_T605_70yrs_Male |
Tumor_Prostate_T3bN0M0_WT_T605_70yrs_Male |
Prostate Cancer (T3bN0M0) from 70-year-old male named T605 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.07% |
85.68% |
|
|
64.52 |
99.82% |
Hom_Tumor_Prostate_T2aN0M1b_MissenseMutation_T607_68yrs_Male |
Tumor_Prostate_T2aN0M1b_MissenseMutation_T607_68yrs_Male |
Prostate Cancer (T2aN0M1b) from 68-year-old male named T607 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
86.39% |
82.59% |
|
|
68.17 |
99.80% |
Hom_Tumor_Prostate_T2cN0M1b_MissenseMutation_T608_50yrs_Male |
Tumor_Prostate_T2cN0M1b_MissenseMutation_T608_50yrs_Male |
Prostate Cancer (T2cN0M1b) from 50-year-old male named T608 with Missense_Mutation FOXA1 Mutation |
Male |
hg38 |
88.78% |
84.69% |
|
|
73.29 |
99.44% |
Hom_Tumor_Prostate_T1cN0M1b_InFrameDel_T609_62yrs_Male |
Tumor_Prostate_T1cN0M1b_InFrameDel_T609_62yrs_Male |
Prostate Cancer (T1cN0M1b) from 62-year-old male named T609 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.01% |
85.02% |
|
|
69.03 |
99.79% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T60_77yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T60_77yrs_Male |
Prostate Cancer (T2cN0M0) from 77-year-old male named T60 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.89% |
85.77% |
|
|
77.41 |
99.80% |
Hom_Tumor_Prostate_T3aN0M0_WT_T61_70yrs_Male |
Tumor_Prostate_T3aN0M0_WT_T61_70yrs_Male |
Prostate Cancer (T3aN0M0) from 70-year-old male named T61 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.05% |
85.72% |
|
|
68.95 |
99.81% |
Hom_Tumor_Prostate_T2aN0M1b_WT_T611_76yrs_Male |
Tumor_Prostate_T2aN0M1b_WT_T611_76yrs_Male |
Prostate Cancer (T2aN0M1b) from 76-year-old male named T611 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.09% |
85.08% |
|
|
68.29 |
99.81% |
Hom_Tumor_Prostate_NAN0M0_InFrameDel_T612_77yrs_Male |
Tumor_Prostate_NAN0M0_InFrameDel_T612_77yrs_Male |
Prostate Cancer (NAN0M0) from 77-year-old male named T612 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.24% |
85.64% |
|
|
75.43 |
99.81% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T613_68yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T613_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named T613 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
85.63% |
82.03% |
|
|
73.91 |
99.80% |
Hom_Tumor_Prostate_T1cN0M0_WT_T62_56yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T62_56yrs_Male |
Prostate Cancer (T1cN0M0) from 56-year-old male named T62 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.20% |
85.61% |
|
|
82.49 |
99.83% |
Hom_Tumor_Prostate_T2bN0M1b_InFrameDel_T63_76yrs_Male |
Tumor_Prostate_T2bN0M1b_InFrameDel_T63_76yrs_Male |
Prostate Cancer (T2bN0M1b) from 76-year-old male named T63 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.53% |
84.97% |
|
|
87.40 |
99.43% |
Hom_Tumor_Prostate_T3bNAM0_WT_T637_57yrs_Male |
Tumor_Prostate_T3bNAM0_WT_T637_57yrs_Male |
Prostate Cancer (T3bNAM0) from 57-year-old male named T637 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.03% |
82.05% |
|
|
66.39 |
99.77% |
Hom_Tumor_Prostate_T3NAM0_WT_T638_69yrs_Male |
Tumor_Prostate_T3NAM0_WT_T638_69yrs_Male |
Prostate Cancer (T3NAM0) from 69-year-old male named T638 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
87.09% |
83.34% |
|
|
63.15 |
99.76% |
Hom_Tumor_Prostate_T2cN0M0_InFrameDel_T64_66yrs_Male |
Tumor_Prostate_T2cN0M0_InFrameDel_T64_66yrs_Male |
Prostate Cancer (T2cN0M0) from 66-year-old male named T64 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
87.98% |
84.01% |
|
|
60.21 |
99.80% |
Hom_Tumor_Prostate_T2aN0M0_WT_T643_68yrs_Male |
Tumor_Prostate_T2aN0M0_WT_T643_68yrs_Male |
Prostate Cancer (T2aN0M0) from 68-year-old male named T643 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.36% |
84.92% |
|
|
78.64 |
99.82% |
Hom_Tumor_Prostate_NAN0M0_WT_T659_64yrs_Male |
Tumor_Prostate_NAN0M0_WT_T659_64yrs_Male |
Prostate Cancer (NAN0M0) from 64-year-old male named T659 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.61% |
84.50% |
|
|
66.57 |
99.73% |
Hom_Tumor_Prostate_T3bN1M0_WT_T67_51yrs_Male |
Tumor_Prostate_T3bN1M0_WT_T67_51yrs_Male |
Prostate Cancer (T3bN1M0) from 51-year-old male named T67 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.27% |
83.28% |
|
|
85.02 |
99.73% |
Hom_Tumor_Prostate_T2cN0M0_WT_T685_74yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T685_74yrs_Male |
Prostate Cancer (T2cN0M0) from 74-year-old male named T685 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
86.99% |
83.28% |
|
|
62.34 |
99.70% |
Hom_Tumor_Prostate_T3aN1M1a_WT_T69_75yrs_Male |
Tumor_Prostate_T3aN1M1a_WT_T69_75yrs_Male |
Prostate Cancer (T3aN1M1a) from 75-year-old male named T69 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.10% |
83.67% |
|
|
71.73 |
99.56% |
Hom_Tumor_Prostate_T1aN0M0_WT_T6_59yrs_Male |
Tumor_Prostate_T1aN0M0_WT_T6_59yrs_Male |
Prostate Cancer (T1aN0M0) from 59-year-old male named T59 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.80% |
85.47% |
|
|
91.04 |
99.77% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T716_53yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T716_53yrs_Male |
Prostate Cancer (T2aN0M0) from 53-year-old male named T716 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
84.79% |
81.10% |
|
|
81.46 |
99.74% |
Hom_Tumor_Prostate_T3cN0M0_WT_T71_61yrs_Male |
Tumor_Prostate_T3cN0M0_WT_T71_61yrs_Male |
Prostate Cancer (T3cN0M0) from 61-year-old male named T71 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.63% |
85.37% |
|
|
83.36 |
99.62% |
Hom_Tumor_Prostate_T2cN0M0_WT_T717_65yrs_Male |
Tumor_Prostate_T2cN0M0_WT_T717_65yrs_Male |
Prostate Cancer (T2cN0M0) from 65-year-old male named T717 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
90.25% |
86.23% |
|
|
63.26 |
99.55% |
Hom_Tumor_Prostate_T1cN0M0_InFrameDel_T727_60yrs_Male |
Tumor_Prostate_T1cN0M0_InFrameDel_T727_60yrs_Male |
Prostate Cancer (T1cN0M0) from 60-year-old male named T727 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
87.82% |
83.79% |
|
|
65.08 |
99.54% |
Hom_Tumor_Prostate_T3aN0M0_InFrameDel_T728_68yrs_Male |
Tumor_Prostate_T3aN0M0_InFrameDel_T728_68yrs_Male |
Prostate Cancer (T3aN0M0) from 68-year-old male named T728 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
89.34% |
85.23% |
|
|
60.15 |
99.80% |
Hom_Tumor_Prostate_T3bNxM0_WT_T729_64yrs_Male |
Tumor_Prostate_T3bNxM0_WT_T729_64yrs_Male |
Prostate Cancer (T3bNxM0) from 64-year-old male named T729 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
89.03% |
84.04% |
|
|
64.08 |
99.64% |
Hom_Tumor_Prostate_T3aN0M0_WT_T72_72yrs_Male |
Tumor_Prostate_T3aN0M0_WT_T72_72yrs_Male |
Prostate Cancer (T3aN0M0) from 72-year-old male named T72 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.77% |
84.57% |
|
|
66.97 |
99.65% |
Hom_Tumor_Prostate_T1cN0M0_WT_T78_74yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T78_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named T78 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.09% |
83.90% |
|
|
66.16 |
99.28% |
Hom_Tumor_Prostate_T3aN0M0_FrameShiftDel_T85_75yrs_Male |
Tumor_Prostate_T3aN0M0_FrameShiftDel_T85_75yrs_Male |
Prostate Cancer (T3aN0M0) from 75-year-old male named T85 with Frame_Shift_Ins FOXA1 Mutation |
Male |
hg38 |
89.17% |
84.47% |
|
|
78.69 |
99.55% |
Hom_Tumor_Prostate_T2aN0M0_InFrameDel_T92_75yrs_Male |
Tumor_Prostate_T2aN0M0_InFrameDel_T92_75yrs_Male |
Prostate Cancer (T2aN0M0) from 75-year-old male named T92 with In_Frame_Del FOXA1 Mutation |
Male |
hg38 |
88.91% |
84.41% |
|
|
77.27 |
99.85% |
Hom_Tumor_Prostate_T1cN0M0_WT_T96_74yrs_Male |
Tumor_Prostate_T1cN0M0_WT_T96_74yrs_Male |
Prostate Cancer (T1cN0M0) from 74-year-old male named T96 with Wild-Type FOXA1 Mutation |
Male |
hg38 |
88.90% |
84.41% |
|
|
81.32 |
99.80% |
Hom_Normal_AdjacentEsophagealTissue_Rep1 |
Normal_AdjacentEsophagealTissue_Rep1 |
Adjacent Normal Esophageal Tissue,, Replicate 1 |
- |
hg38 |
85.51% |
79.51% |
87.70% |
89.29% |
21.88 |
99.61% |
Hom_Normal_AdjacentEsophagealTissue_Rep2 |
Normal_AdjacentEsophagealTissue_Rep2 |
Adjacent Normal Esophageal Tissue, Replicate 2 |
- |
hg38 |
85.48% |
79.33% |
87.08% |
88.72% |
19.77 |
99.57% |
Hom_Normal_AdjacentEsophagealTissue_Rep3 |
Normal_AdjacentEsophagealTissue_Rep3 |
Adjacent Normal Esophageal Tissue, Replicate 3 |
- |
hg38 |
85.27% |
79.50% |
87.39% |
88.77% |
19.20 |
99.60% |
Hom_Normal_AdjacentEsophagealTissue_Rep4 |
Normal_AdjacentEsophagealTissue_Rep4 |
Adjacent Normal Esophageal Tissue, Replicate 4 |
- |
hg38 |
85.02% |
78.88% |
87.07% |
88.55% |
19.72 |
99.61% |
Hom_Normal_AdjacentEsophagealTissue_Rep5 |
Normal_AdjacentEsophagealTissue_Rep5 |
Adjacent Normal Esophageal Tissue, Replicate 5 |
- |
hg38 |
84.41% |
78.60% |
87.52% |
89.19% |
23.45 |
99.65% |
Hom_Normal_AdjacentEsophagealTissue_Rep6 |
Normal_AdjacentEsophagealTissue_Rep6 |
Adjacent Normal Esophageal Tissue, Replicate 6 |
- |
hg38 |
84.44% |
78.25% |
87.36% |
88.35% |
15.80 |
99.40% |
Hom_Normal_AdjacentEsophagealTissue_Rep7 |
Normal_AdjacentEsophagealTissue_Rep7 |
Adjacent Normal Esophageal Tissue, Replicate 7 |
- |
hg38 |
84.44% |
78.09% |
87.42% |
88.96% |
21.43 |
99.56% |
Hom_Normal_AdjacentEsophagealTissue_Rep8 |
Normal_AdjacentEsophagealTissue_Rep8 |
Adjacent Normal Esophageal Tissue, Replicate 8 |
- |
hg38 |
90.02% |
83.20% |
86.95% |
85.60% |
20.65 |
99.60% |
Hom_Normal_AdjacentEsophagealTissue_Rep9 |
Normal_AdjacentEsophagealTissue_Rep9 |
Adjacent Normal Esophageal Tissue, Replicate 9 |
- |
hg38 |
84.64% |
78.95% |
87.43% |
88.45% |
13.51 |
99.34% |
Hom_ProstateGland_54yrs_Male |
ProstateGland_54yrs_Male |
Prostate Gland from 54-year-old male adult |
male |
hg38 |
80.12% |
74.26% |
89.29% |
91.74% |
37.71 |
99.60% |